{"gene":"POT1","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2001,"finding":"POT1 (protection of telomeres 1) protein binds the single-stranded G-rich telomeric DNA overhang at chromosome ends. Deletion of fission yeast pot1+ causes rapid loss of telomeric DNA and chromosome circularization, establishing a direct role in chromosome end protection.","method":"Genetic deletion in S. pombe (pot1+ knockout), in vitro DNA binding assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — direct binding demonstrated in vitro, genetic deletion with clear chromosomal phenotype, foundational paper widely replicated","pmids":["11349150"],"is_preprint":false},{"year":2003,"finding":"Crystal structure of the N-terminal DNA-binding domain of S. pombe Pot1p complexed with single-stranded telomeric DNA at 1.9 Å resolution. The protein adopts an OB fold with two loops forming a clamp; sequence specificity arises from DNA self-recognition involving base-stacking and unusual G-T base pairs.","method":"X-ray crystallography at 1.9 Å resolution","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution crystal structure with functional validation of sequence specificity","pmids":["14614509"],"is_preprint":false},{"year":2003,"finding":"Human POT1 acts as a positive regulator of telomere length in a telomerase-dependent manner. Overexpression of hPOT1 splice variants lengthened telomeres only in telomerase-positive cells, indicating POT1 facilitates telomerase-mediated elongation.","method":"Overexpression of POT1 splice variants in telomerase-positive vs. telomerase-negative cell lines, telomere length analysis","journal":"Current Biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — functional overexpression with telomerase-dependence control, single lab","pmids":["12781132"],"is_preprint":false},{"year":2003,"finding":"POT1 interacts with the TRF1 complex, and its binding to telomeres is regulated by TRF1 in response to telomere length. A POT1 mutant lacking the DNA-binding domain (acting as dominant negative) abrogates TRF1-mediated telomere length control and induces rapid telomere elongation, identifying POT1 as a terminal transducer of TRF1 telomere length signaling.","method":"Co-immunoprecipitation, dominant-negative POT1 expression, telomere length assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP, dominant-negative genetics, replicated by multiple labs","pmids":["12768206"],"is_preprint":false},{"year":2002,"finding":"Epitope-tagged human POT1 localizes to telomeres in interphase nuclei as shown by indirect immunofluorescence. Multiple splice variants of hPOT1 exist and differ in their ability to form complexes with single-stranded telomeric DNA.","method":"Indirect immunofluorescence (EMSA for splice variant DNA binding)","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — direct localization by immunofluorescence, EMSA for DNA binding, single lab","pmids":["12391173"],"is_preprint":false},{"year":2004,"finding":"Crystal structure of the N-terminal half of human POT1 bound to the telomeric ssDNA decamer TTAGGGTTAG at 1.73 Å resolution. hPOT1 contains two OB folds: the first binds the first six nucleotides, while the second OB fold binds and protects the 3' end of the ssDNA.","method":"X-ray crystallography at 1.73 Å resolution with in vitro binding assays","journal":"Nature Structural & Molecular Biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — high-resolution crystal structure with in vitro binding validation","pmids":["15558049"],"is_preprint":false},{"year":2004,"finding":"The minimal binding site for human POT1 on telomeric ssDNA is the nonamer 5'-TAGGGTTAG-3'. Deletion of the OB fold abolishes DNA binding. POT1 can bind internally to multimeric [TTAGGG]n arrays as well as at 3' ends.","method":"In vitro binding assays (EMSA, deletion and substitution mutants)","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro binding with mutagenesis, well-defined minimal binding site","pmids":["14715659"],"is_preprint":false},{"year":2004,"finding":"A novel telomeric protein PIP1 (also identified as PTOP/TPP1) binds both POT1 and TIN2, tethering POT1 to the TRF1 complex. ShRNA depletion of PIP1 or POT1 causes telomere elongation, indicating PIP1 contributes to telomere length control through POT1 recruitment.","method":"Mass spectrometry identification, co-immunoprecipitation, shRNA knockdown, telomere length assays","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — MS identification, Co-IP, functional knockdown with defined phenotype, replicated independently","pmids":["15231715"],"is_preprint":false},{"year":2004,"finding":"PTOP (also called PIP1/TPP1) interacts with the C-terminus of POT1 and recruits it to telomeres. RNAi-mediated inhibition of PTOP or disruption of the PTOP-POT1 interaction prevents POT1 telomeric localization and extends telomere length.","method":"Co-immunoprecipitation, RNAi knockdown, fluorescence imaging, telomere length assays","journal":"Nature Cell Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, RNAi with functional phenotype, direct localization experiment, independently replicated","pmids":["15181449"],"is_preprint":false},{"year":2005,"finding":"hPOT1 disrupts telomeric G-quadruplex structures by forming a stoichiometric complex with the DNA (not catalytically), freeing the 3' tail and restoring processive telomerase elongation of G-quadruplex primers in vitro.","method":"In vitro telomerase extension assay, gel mobility shift assay with purified recombinant hPOT1","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro assay with purified proteins, stoichiometry established","pmids":["16043710"],"is_preprint":false},{"year":2005,"finding":"Human POT1 acts as a negative regulator of telomerase in vitro through its DNA-binding activity. POT1 bound at the extreme 3' end of the telomere blocks telomerase, but when bound one repeat before the 3' end (leaving an 8-nt tail), it creates a preferred substrate for telomerase with improved activity and processivity.","method":"In vitro telomerase extension assay with recombinant hPOT1, crystal-structure guided positioning experiments","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro assay with mutagenesis and structural basis, multiple conditions tested","pmids":["15792951","15632080"],"is_preprint":false},{"year":2005,"finding":"POT1 stimulates WRN and BLM RecQ helicases to unwind long telomeric forked duplexes and D-loop structures. This stimulation requires telomeric sequence in the duplex regions. Purified POT1 directly binds WRN and BLM in vitro.","method":"In vitro helicase assay with purified proteins, pulldown assay for protein-protein interaction","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro helicase assay plus direct pulldown binding, multiple substrates tested","pmids":["16030011"],"is_preprint":false},{"year":2005,"finding":"RNAi-mediated depletion of POT1 in human cells reduces the telomeric 3' overhang DNA and induces a transient DNA damage response at all telomeres in G1, but does not cause telomere fusions or cell cycle arrest. POT1 also determines the correct sequence at chromosome ends: normally the recessed 5' end ends on ATC-5', and this positional specificity is lost upon POT1 depletion.","method":"RNAi knockdown, telomere overhang assay, fluorescence imaging of DNA damage foci, telomere sequencing","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — RNAi with multiple orthogonal readouts (overhang assay, DDR foci, sequence analysis), specific mechanistic conclusions","pmids":["15973431"],"is_preprint":false},{"year":2005,"finding":"POT1 and TRF2 interact to form a complex with telomeric DNA. POT1 knockdown causes loss of telomeric single-stranded overhangs, apoptosis, chromosomal instability, and senescence. POT1 overexpression partially rescues TRF2-dominant-negative-induced telomere dysfunction.","method":"Co-immunoprecipitation, RNAi knockdown, overexpression rescue experiments, telomere overhang assay","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP for protein interaction, RNAi phenotype with rescue, single lab","pmids":["15657433"],"is_preprint":false},{"year":2006,"finding":"Conditional deletion of mouse Pot1a activates a DNA damage response at telomeres, causing p53-dependent replicative senescence. Pot1a-deficient cells show overall telomere length and 3' overhang elongation and aberrant homologous recombination (telomere sister chromatid exchanges and telomere circle formation) that requires NBS1.","method":"Conditional knockout in mouse cells, genetic epistasis (NBS1 requirement), telomere FISH, telomere overhang assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple phenotypic readouts plus epistasis (NBS1), replicated independently","pmids":["16839876"],"is_preprint":false},{"year":2006,"finding":"Mouse telomeres contain two POT1 paralogs with distinct functions: POT1a represses a DNA damage signal at telomeres, while POT1b regulates the amount of single-stranded DNA at the telomere terminus. Double knockout causes a DNA damage signal, endoreduplication, and senescence.","method":"Conditional deletion of POT1a and/or POT1b in mouse cells, complementation experiments, telomere overhang and FISH assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO single/double knockouts with complementation, multiple phenotypic readouts, replicated","pmids":["16839877"],"is_preprint":false},{"year":2007,"finding":"Crystal structure of the TPP1 OB domain reveals structural similarity to the ciliate TEBP-beta subunit. TPP1 and POT1 form a complex that increases telomerase activity and processivity; TPP1-POT1 on telomeric DNA stimulates the telomerase core enzyme, switching from telomerase inhibition to a processivity factor role.","method":"X-ray crystallography of TPP1 OB domain, in vitro telomerase processivity assay with purified POT1-TPP1","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus reconstituted in vitro telomerase assay, independently replicated by two concurrent papers","pmids":["17237768","17237767"],"is_preprint":false},{"year":2007,"finding":"POT1 prevents activation of ATR kinase signaling at telomeres independently of TRF2's repression of ATM. Depletion of POT1 selectively activates ATR (not ATM), while TRF2 depletion selectively activates ATM. These two shelterin proteins act independently in repressing the two DNA damage response pathways.","method":"Conditional depletion in ATM-/- and/or ATR-/- cell backgrounds (epistasis), DDR phosphorylation assays","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis across multiple kinase-null backgrounds, replicated independently","pmids":["17687332"],"is_preprint":false},{"year":2007,"finding":"Tpp1 (TPP1 homolog in fission yeast) forms a complex with Pot1, which recruits effector molecules Ccq1 and Poz1. Poz1 bridges Pot1-Tpz1 and Taz1-Rap1, connecting single-stranded and double-stranded telomeric DNA regions, analogous to the mammalian shelterin architecture.","method":"Co-immunoprecipitation, yeast genetics, protein interaction mapping","journal":"Science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and genetic analysis in fission yeast, single lab","pmids":["18535244"],"is_preprint":false},{"year":2007,"finding":"The telomere protection function of mammalian Pot1 requires its interaction with Tpp1. Using Tpp1-knockdown cells and Pot1 variants, it was shown that Tpp1 is required for Pot1 to protect chromosome ends (suppress ATR signaling and prevent fusions), not just for telomere length regulation.","method":"RNAi knockdown of Tpp1, complementation with POT1 variants, conditional knockouts, telomere dysfunction assays","journal":"Nature Structural & Molecular Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic approaches, complementation experiments, clear separation-of-function","pmids":["17632522"],"is_preprint":false},{"year":2008,"finding":"Domain-swap and separation-of-function analysis shows that the DNA-binding domain of POT1a specifies its ability to repress the ATR DNA damage response, while POT1b's ability to control 5'-end resection requires the TPP1-binding domain plus a region between amino acids 300–350. Human POT1 combines both functional features. Neither POT1a nor POT1b differs in in vitro DNA binding properties.","method":"Domain-swap mutagenesis, complementation of POT1a/b knockout cells, telomere damage assays","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — systematic domain swapping with functional complementation, multiple phenotypic readouts","pmids":["18955498"],"is_preprint":false},{"year":2008,"finding":"POT1 OB-fold-dependent binding to ssDNA and association with TPP1 are both required in cis for POT1 to protect telomeres and inhibit RPA localization. TRF2 binding by POT1 is dispensable for protection but promotes robust POT1 loading onto telomeric chromatin.","method":"Separation-of-function POT1 mutants, fluorescence imaging, RPA co-localization assays","journal":"Molecular and Cellular Biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple separation-of-function mutants, orthogonal assays, mechanistic conclusion on RPA exclusion","pmids":["18519588"],"is_preprint":false},{"year":2009,"finding":"TIN2 is required for the telomeric accumulation of TPP1/POT1. Upon TIN2 deletion, telomeres lose TPP1/POT1a, accumulate RPA, and activate ATR signaling. TIN2's major role is to stabilize TPP1/POT1 on ss telomeric DNA to allow RPA exclusion and ATR repression.","method":"Conditional knockout of TIN2, telomere protein localization (immunofluorescence), ATR signaling assays","journal":"Molecular Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple mechanistic readouts, epistasis with ATR pathway, single lab but multiple orthogonal methods","pmids":["22099311"],"is_preprint":false},{"year":2009,"finding":"POT1 discriminates ssDNA over RNA via a single deoxythymidine in each telomeric repeat. A Phe62 residue creates a hydrophobic region that buries the 2'-OH of a ribouridine and eliminates favorable hydrogen bonds. TPP1 greatly augments POT1's RNA discrimination. Crystal structure of hPOT1 with a ribouridine-substituted DNA confirms the mechanism.","method":"In vitro binding assays, X-ray crystallography of hPOT1 with ribouridine-substituted DNA, site-directed mutagenesis (F62Y)","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus mutagenesis and binding assays, mechanistically detailed","pmids":["20080730"],"is_preprint":false},{"year":2009,"finding":"Human POT1 has higher affinity for telomeric G-rich ssDNA than RPA. Under conditions where both WRN and POT1 are limiting, both G- and C-rich telomeric strands shorten. A POT1 OB-fold fragment can restore C-strand (but not G-strand) replication in WRN-depleted cells, suggesting POT1 binding to the lagging strand template enables DNA synthesis uncoupling.","method":"RNAi knockdown of WRN and/or POT1, telomere strand-specific assays, in vitro competition binding assays","journal":"Genes & Development","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — genetic knockdown with strand-specific telomere readouts plus in vitro binding, single lab","pmids":["20008939"],"is_preprint":false},{"year":2010,"finding":"POT1-TPP1 enhances telomerase processivity by (1) slowing primer dissociation rate and (2) increasing translocation efficiency. A single POT1-TPP1-DNA interaction is necessary and sufficient. POT1-TPP1 can function substoichiometrically, supporting a recruitment function.","method":"In vitro telomerase processivity assays with purified POT1-TPP1, kinetic analysis of primer dissociation and translocation steps","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro assay dissecting individual kinetic steps, multiple controls including template mutant","pmids":["20094033"],"is_preprint":false},{"year":2011,"finding":"TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric ssDNA. hnRNPA1 specifically displaces RPA (but not POT1) from telomeric ssDNA. TERRA inhibits this activity in early S phase; TERRA decline in late S phase unleashes hnRNPA1-mediated RPA displacement. TERRA re-accumulation after S phase promotes POT1 binding by removing hnRNPA1.","method":"Purified protein assays, cell extract fractionation, fluorescence imaging of RPA/POT1 at telomeres, TERRA manipulation experiments","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reconstitution with purified proteins plus cell-based validation, multiple orthogonal methods","pmids":["21399625"],"is_preprint":false},{"year":2011,"finding":"Multiple POT1-TPP1 heterodimers can coat long telomeric ssDNA (72–144 nt), forming compact, potentially ordered nucleoprotein structures. POT1-TPP1 (but not POT1 alone) leads to compaction of the coated ssDNA as visualized by electron microscopy.","method":"EMSA, size-exclusion chromatography, transmission electron microscopy","journal":"Journal of Molecular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple biochemical methods with structural imaging, single lab","pmids":["21596049"],"is_preprint":false},{"year":2012,"finding":"POT1 unfolds G-quadruplex DNA in a stepwise, sequential manner (one OB fold at a time, 3' to 5'). In contrast, the POT1-TPP1 complex induces continuous folding and unfolding dynamics and slides back and forth on telomeric DNA, including on mutant telomeric DNA to which POT1 alone cannot bind.","method":"Single-molecule FRET (smFRET) imaging","journal":"Structure","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — single-molecule real-time imaging with controls, single lab","pmids":["22981946"],"is_preprint":false},{"year":2014,"finding":"TRF1 deploys TIN2 and the TPP1/POT1 heterodimers to prevent ATR activation during telomere replication and repress sister telomere associations. BLM facilitates lagging-strand telomeric DNA synthesis downstream of TRF1. These are two mechanistically distinct TRF1 functions in replication.","method":"Conditional knockouts (TRF1, BLM, TPP1, Rap1) in mouse cells, epistasis analysis, TRF1/TIN2 mutant expression","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple conditional KOs with epistasis, separation of distinct TRF1 functions, rigorous controls","pmids":["25344324"],"is_preprint":false},{"year":2014,"finding":"TIN2-tethered TPP1/POT1 is sufficient for telomere protection even without TRF1 binding; when TIN2 is tethered to telomeres via TRF2 (using an artificial RCT-TIN2-L247E fusion), chromosome end protection by TRF2, TPP1/POT1a, and TPP1/POT1b is fully restored.","method":"TIN2 allele engineering (L247E mutation), fusion protein expression, conditional complementation, telomere dysfunction assays","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — engineered mutant alleles with functional complementation, single lab","pmids":["24469404"],"is_preprint":false},{"year":2015,"finding":"DNA-PKcs phosphorylates hnRNP-A1 during G2/M phases to facilitate the RPA-to-POT1 switch on telomeric 3' overhangs. Loss of DNA-PKcs or its phosphorylation of hnRNP-A1 impairs this switch, causing DNA damage responses at telomeres during mitosis and fragile telomeres.","method":"Kinase assays, phospho-mutant expression, RPA/POT1 co-localization at telomeres, DNA damage foci assays","journal":"Nucleic Acids Research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical phosphorylation assay plus cellular imaging with functional consequence, single lab","pmids":["25999341"],"is_preprint":false},{"year":2016,"finding":"A POT1 S322L mutation (POT1-CP) found in Coats plus disease is defective in regulating telomerase (leading to telomere elongation) and in maintenance of the telomeric C strand, causing extended 3' overhangs and stochastic telomere truncations. POT1-CP can bind TPP1 and telomeres and block ATR signaling normally. POT1/CST-dependent telomere fill-in is implicated as the mechanism disrupted in Coats plus.","method":"Patient-derived mutation functional characterization, telomere length assays, overhang assays, telomere FISH, telomerase regulation assays, epistasis with telomerase","journal":"Genes & Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal assays on patient mutation, functional separation from other POT1 activities, disease mechanism established","pmids":["27013236"],"is_preprint":false},{"year":2016,"finding":"POT1 inactivation causes telomere fragility, replication fork stalling, ATR-dependent DNA damage signaling, and telomere elongation. These phenotypes are linked to impaired CST (CTC1-STN1-TEN1) function at telomeres. Cancer cells lacking POT1 function require attenuation of the ATR kinase pathway to proliferate.","method":"Conditional murine POT1a depletion in lymphoid progenitors, human/mouse cancer-associated POT1 mutation analysis, telomere replication assays, ATR pathway epistasis","journal":"Cell Reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic model plus cancer-associated mutations, multiple readouts, single lab","pmids":["27239034"],"is_preprint":false},{"year":2016,"finding":"Human POT1 OB-fold mutations found in cancers fail to bind ssDNA, elicit a DNA damage response, and promote chromosome fusions via alternative NHEJ (A-NHEJ). Combined conditional deletion of Pot1a/b and p53 in mouse mammary epithelium produces highly invasive breast carcinomas with telomeric breakage-fusion-bridge cycles.","method":"OB-fold mutant expression, telomere FISH, A-NHEJ assays, conditional KO mouse model","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple human cancer mutations functionally characterized, mouse conditional KO model, A-NHEJ pathway identified","pmids":["27869160"],"is_preprint":false},{"year":2017,"finding":"Crystal structure of the C-terminal portion of human POT1 (POT1C) complexed with the POT1-binding motif of TPP1. POT1C contains a third OB fold and a Holliday junction resolvase-like (HJRL) domain; both domains are essential for TPP1 binding. The POT1-TPP1 complex adopts an elongated V-shaped conformation. Cancer-associated missense mutations in POT1C disrupt the POT1-TPP1 interaction, destabilize POT1, and impair telomeric DNA binding.","method":"X-ray crystallography, biochemical binding assays, cancer mutation characterization","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 1 / Strong — two independent crystal structures with biochemical validation, replicated in same year by concurrent paper (PMID:28393830)","pmids":["28393832","28393830"],"is_preprint":false},{"year":2019,"finding":"POT1 His266 is a key residue mediating length-dependent regulation of telomerase. When multiple POT1-TPP1 proteins coat physiologically relevant lengths of telomeric ssDNA, they inhibit telomerase. The CLL-associated H266L mutation abrogates this inhibitory function of multi-POT1-TPP1 coating, leading to telomere overextension. Hydroxyl radical footprinting reveals conformational changes around His266 dependent on ssDNA substrate length.","method":"Hydroxyl radical footprinting coupled with mass spectrometry, in vitro telomerase assay, binding assays with H266L mutant POT1-TPP1","journal":"PNAS","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — novel biophysical method plus functional assay, single lab, single publication","pmids":["31685617"],"is_preprint":false},{"year":2019,"finding":"TSPYL5 prevents poly-ubiquitination and proteasomal degradation of POT1 specifically in ALT+ cancer cells. In the absence of TSPYL5, USP7 deubiquitinase activity activates POT1 E3 ubiquitin ligase(s), promoting POT1 poly-ubiquitination. PML body environment in ALT cells potentiates POT1 degradation.","method":"Co-immunoprecipitation, ubiquitination assays, siRNA knockdown, proteasome inhibitor experiments","journal":"Molecular Cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus ubiquitination assay and siRNA epistasis, single lab","pmids":["31278054"],"is_preprint":false},{"year":2019,"finding":"SerRS (seryl tRNA synthetase) directly binds to telomeric DNA repeats in the nucleus and tethers additional POT1 proteins to telomeres through a direct interaction between the UNE-S domain of SerRS and the OB1 domain of POT1. Enrichment of POT1 at telomeres by SerRS prevents telomerase recruitment and causes progressive telomere shortening.","method":"Co-immunoprecipitation, pulldown, ChIP, telomere length assays","journal":"Signal Transduction and Targeted Therapy","confidence":"Low","confidence_rationale":"Tier 3 / Weak — Co-IP and pulldown but single lab, single publication, indirect functional readout","pmids":["31815007"],"is_preprint":false},{"year":2019,"finding":"TIN2 stimulates telomerase processivity in vitro, and this stimulation requires a functional TPP1 TEL patch (the telomerase-recruiting surface of TPP1), indicating TIN2 functions with TPP1/POT1 as a functional shelterin subcomplex to stimulate telomerase.","method":"In vitro telomerase processivity assay with purified TIN2/TPP1/POT1, TPP1 TEL-patch mutants","journal":"Molecular and Cellular Biology","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — reconstituted in vitro assay with mutagenesis, single lab","pmids":["31383750"],"is_preprint":false},{"year":2020,"finding":"POT1 unfolds telomeric G-quadruplex structures via a conformational selection mechanism (not induced fit): POT1 binding is coupled to an obligatory prior unfolding of the G-quadruplex. The final complex has 2 POT1 per 24 nt DNA. Binding to folded G-quadruplex is four orders of magnitude slower than to single-stranded DNA.","method":"Stopped-flow kinetics, spectroscopic titration, isothermal calorimetry, analytical ultracentrifugation, circular dichroism, molecular dynamics simulation","journal":"Nucleic Acids Research","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biophysical methods with quantitative fitting, single lab but very rigorous","pmids":["32232414"],"is_preprint":false},{"year":2020,"finding":"Complete conditional deletion of POT1 in human HEK293E cells causes rapid telomere elongation and length heterogeneity, branched telomeric DNA structures, telomeric R-loops, and telomere fragility. Inactivation of homology-directed repair machinery suppresses these defects, identifying suppression of HDR as a major function of human POT1.","method":"Conditional gene deletion (CRISPR-based), telomeric chromatin isolation proteomics, epistasis with HDR pathway inhibitors, telomere FISH","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple orthogonal readouts plus HDR epistasis, proteomics","pmids":["33073402"],"is_preprint":false},{"year":2020,"finding":"POT1 dysfunction (mutations) causes replication stress manifesting as increased mitotic DNA synthesis at telomeres. Depletion of nuclear pore complex (NPC) subunits worsens telomere damage in POT1-mutant cells. Mutant-POT1-expressing cells relocalize dysfunctional telomeres to the nuclear periphery via nuclear F-actin polymerization.","method":"CRISPR interference, biotin-based proximity labeling (BioID), nuclear pore subunit depletion, nuclear F-actin imaging","journal":"Genes & Development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR genetics with proteomics and imaging, single lab","pmids":["33122293"],"is_preprint":false},{"year":2021,"finding":"Cancer-associated POT1 mutations engineered into human embryonic stem cells and hematopoietic stem cells cause telomere elongation without detectable telomere damage response or ATR signaling. This indicates caPOT1 mutations are selected in cancer for their ability to elongate telomeres rather than for induction of DNA damage.","method":"CRISPR engineering of cancer-associated POT1 mutations in hESCs and HSCs, telomere damage assays, competition experiments in vitro and in vivo","journal":"EMBO Journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — precise CRISPR engineering, multiple stem cell types, in vivo competition experiments, clear mechanistic separation","pmids":["33934394"],"is_preprint":false},{"year":2021,"finding":"Mouse POT1b (but not POT1a) enhances telomerase recruitment to telomeres through three specific amino acids in its TPP1-interacting C-terminus, coordinating G-strand synthesis. POT1a conversely negatively regulates telomere length by inhibiting telomerase recruitment.","method":"Conditional mouse KO, complementation with POT1a/b swap mutants and point mutants, telomere length assays, telomerase recruitment assays","journal":"Nature Communications","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KOs with domain-swap and point-mutation complementation, multiple mechanistic readouts","pmids":["34535663"],"is_preprint":false},{"year":2022,"finding":"Cryo-EM structures of human telomerase bound to TPP1 (3.2 Å) and to TPP1-POT1 (3.9 Å) reveal the interactions required for telomerase recruitment. TPP1-POT1 stabilizes the telomeric DNA in the active site, reveals an unexpected DNA exit path and a DNA anchor site on telomerase important for processivity.","method":"Cryo-electron microscopy at 3.2–3.9 Å resolution","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — near-atomic resolution cryo-EM structure of the full telomerase-TPP1-POT1 complex with functional validation","pmids":["35201900"],"is_preprint":false},{"year":2023,"finding":"Human POT1 caps the telomeric double-stranded/single-stranded (ds-ss) DNA junction by recognizing the phosphorylated 5' end of the chromosome via a 'POT-hole' surface. Crystal structures reveal the structural basis of junction binding. Mutation of the POT-hole compromises junction protection in vitro and leads to loss of telomeric 5'-end definition and ATR-DDR induction in cells. Mouse POT1a (not POT1b) contains the POT-hole and binds the junction, explaining why POT1a is sufficient for end protection.","method":"X-ray crystallography of POT1-junction complex, in vitro binding assays, POT-hole mutagenesis, human cell ATR signaling and telomere end-structure assays","journal":"Science","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus mutagenesis and cellular functional validation, explains paralog functional divergence","pmids":["37590346"],"is_preprint":false},{"year":2024,"finding":"Cryo-EM structures of human CST bound to the shelterin heterodimer POT1/TPP1 reveal how CST is recruited to telomeres by POT1. POT1 hinge phosphorylation is required for CST recruitment. Phosphorylated POT1 holds CST-Polα/primase in an inactive (autoinhibited) state; dephosphorylation of POT1 releases CST-Polα/primase into an active state to perform C-strand fill-in synthesis.","method":"Cryo-electron microscopy structure of CST-POT1/TPP1, biochemical assays for POT1 phosphorylation-dependent CST interactions, functional telomere fill-in assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — cryo-EM structure with biochemical and functional validation, disease mutations characterized, mechanistic model for POT1 phospho-switch","pmids":["38838667"],"is_preprint":false}],"current_model":"POT1 is the single-stranded telomeric DNA-binding protein of the shelterin complex that caps chromosome ends through two N-terminal OB folds binding the 3' G-rich overhang and a C-terminal OB/HJRL domain heterodimerizing with TPP1; it prevents ATR kinase activation by excluding RPA from telomeric ssDNA (requiring TIN2-mediated tethering to the duplex-binding shelterin components), caps the ds-ss telomere junction via a 'POT-hole' surface recognizing the phosphorylated 5' chromosome end, bidirectionally regulates telomerase processivity (inhibiting when bound at the 3'-terminus; stimulating when POT1-TPP1 coats the overhang via slowed primer dissociation and enhanced translocation), disrupts G-quadruplex structures by conformational selection, recruits CST-Polα/primase in a phosphorylation-dependent manner to enable C-strand fill-in synthesis, and suppresses homology-directed repair at telomeres."},"narrative":{"mechanistic_narrative":"POT1 is the single-stranded telomeric DNA-binding subunit of the shelterin complex that caps chromosome ends and prevents them from being recognized as DNA damage [PMID:11349150, PMID:15973431]. Discovered first in fission yeast, where its loss causes telomere erosion and chromosome circularization [PMID:11349150], POT1 binds the G-rich 3' overhang through tandem N-terminal OB folds that clamp a minimal nonameric recognition site and protect the 3' terminus [PMID:15558049, PMID:14715659], discriminating DNA from RNA via a phenylalanine that excludes the ribose 2'-OH [PMID:20080730]. It is recruited to telomeres not by direct loading alone but through its C-terminal OB/HJRL domain, which heterodimerizes with TPP1 and is thereby tethered through TIN2 to the duplex-binding shelterin proteins TRF1 and TRF2 [PMID:15231715, PMID:15181449, PMID:28393832, PMID:28393830]; this TIN2-stabilized POT1-TPP1 platform is what excludes RPA from telomeric ssDNA and represses ATR kinase signaling, a pathway POT1 governs independently of TRF2's repression of ATM [PMID:17687332, PMID:18519588, PMID:22099311]. POT1 caps the double-/single-stranded telomere junction by recognizing the phosphorylated 5' chromosome end through a 'POT-hole' surface, defining the precise terminal sequence [PMID:15973431, PMID:37590346]. POT1 bidirectionally tunes telomerase: bound at the extreme 3' terminus it inhibits the enzyme, whereas POT1-TPP1 coating the overhang acts as a processivity factor by slowing primer dissociation and enhancing translocation, with cryo-EM revealing how TPP1-POT1 stabilizes the DNA in the telomerase active site [PMID:15792951, PMID:15632080, PMID:17237768, PMID:17237767, PMID:20094033, PMID:35201900]. It resolves telomeric G-quadruplexes by conformational selection to license telomerase access [PMID:16043710, PMID:32232414], and, through phosphorylation-dependent recruitment of CST-Polα/primase, controls C-strand fill-in synthesis [PMID:27013236, PMID:38838667]. POT1 also suppresses inappropriate homology-directed repair and replication-associated damage at telomeres [PMID:33073402]. Germline and somatic POT1 mutations cause Coats plus disease and drive cancers by elongating telomeres or by abolishing ssDNA binding to trigger end-to-end fusions [PMID:27013236, PMID:27869160, PMID:33934394].","teleology":[{"year":2001,"claim":"Established that a dedicated protein protects single-stranded chromosome ends, defining the founding function of POT1 before any human mechanism was known.","evidence":"Genetic deletion of pot1+ in S. pombe with in vitro ssDNA binding assays","pmids":["11349150"],"confidence":"High","gaps":["Did not resolve how POT1 recognizes the telomeric sequence at atomic level","Mammalian function and complex partners unaddressed"]},{"year":2003,"claim":"Resolved the structural basis of sequence-specific ssDNA recognition, showing OB-fold loops form a clamp and specificity arises from DNA self-recognition.","evidence":"X-ray crystallography of S. pombe Pot1p N-terminal domain bound to ssDNA at 1.9 Å","pmids":["14614509"],"confidence":"High","gaps":["Human POT1 architecture not yet defined","How binding relates to telomerase regulation unknown"]},{"year":2003,"claim":"Connected POT1 to telomere length homeostasis, positioning it as the terminal transducer of TRF1-mediated length signaling rather than only a passive cap.","evidence":"Co-IP, dominant-negative POT1 lacking the DNA-binding domain, and telomere length assays in human cells","pmids":["12768206","12781132"],"confidence":"High","gaps":["Physical bridge between POT1 and TRF1 not identified","Direction of telomerase regulation mechanistically unresolved"]},{"year":2004,"claim":"Defined human POT1's two-OB-fold architecture, minimal recognition site, and identified TPP1/PIP1/PTOP as the adaptor that recruits POT1 to the shelterin core via TIN2.","evidence":"Crystal structure of hPOT1 N-terminus at 1.73 Å, EMSA mutagenesis, MS identification and Co-IP of TPP1/PIP1, shRNA knockdown","pmids":["15558049","14715659","15231715","15181449"],"confidence":"High","gaps":["C-terminal domain structure and TPP1-binding interface not yet resolved","Mechanism of RPA exclusion not yet shown"]},{"year":2005,"claim":"Demonstrated POT1's dual biochemical roles: resolving G-quadruplexes to permit telomerase, and acting as a position-dependent bidirectional regulator of telomerase.","evidence":"Reconstituted in vitro telomerase extension and gel-shift assays with purified recombinant hPOT1","pmids":["16043710","15792951","15632080"],"confidence":"High","gaps":["How POT1 switches from inhibitor to activator awaited the TPP1 cofactor","G-quadruplex resolution mechanism (induced fit vs selection) unresolved"]},{"year":2005,"claim":"Established the cellular consequence of POT1 loss—overhang erosion, loss of 5'-end sequence definition, and a G1 DNA damage response—linking POT1 to terminal structure fidelity.","evidence":"RNAi knockdown with overhang assays, DDR foci imaging, telomere sequencing, plus POT1-TRF2 Co-IP and helicase stimulation assays","pmids":["15973431","15657433","16030011"],"confidence":"High","gaps":["Which DDR kinase POT1 represses not yet specified","Mechanistic basis of 5'-end definition unresolved"]},{"year":2006,"claim":"Genetic dissection in mouse revealed POT1 paralogs with separable functions—POT1a represses DDR while POT1b controls overhang length—and an aberrant HR phenotype dependent on NBS1.","evidence":"Conditional single and double knockouts in mouse cells with complementation, telomere FISH, overhang assays, NBS1 epistasis","pmids":["16839876","16839877"],"confidence":"High","gaps":["Molecular determinants distinguishing POT1a from POT1b functions not mapped","Human single-gene equivalence to two mouse paralogs unclear"]},{"year":2007,"claim":"Defined POT1 as the shelterin component that specifically represses the ATR (not ATM) DNA damage pathway, and showed TPP1 binding is required for protection beyond length control.","evidence":"Conditional depletion across ATM/ATR-null backgrounds, DDR phosphorylation assays, TPP1 knockdown with POT1-variant complementation","pmids":["17687332","17632522","18535244"],"confidence":"High","gaps":["How ATR suppression is achieved mechanistically (RPA exclusion) not yet demonstrated","TPP1-POT1 structural basis of telomerase switch unresolved"]},{"year":2007,"claim":"Identified TPP1 as the cofactor that converts POT1 from a telomerase inhibitor into a processivity factor, with structural similarity to ciliate TEBP-beta.","evidence":"Crystal structure of TPP1 OB domain plus reconstituted in vitro telomerase processivity assays with purified POT1-TPP1","pmids":["17237768","17237767"],"confidence":"High","gaps":["Kinetic basis of processivity enhancement not yet dissected","Stoichiometry of functional POT1-TPP1 unit unknown"]},{"year":2009,"claim":"Established the mechanistic logic of telomere protection: cis ssDNA binding plus TPP1 association are jointly required to exclude RPA, and resolved how POT1 discriminates DNA from RNA.","evidence":"Separation-of-function POT1 mutants with RPA co-localization, crystallography of hPOT1 with ribouridine-substituted DNA, F62Y mutagenesis","pmids":["18519588","18955498","20080730","20008939"],"confidence":"High","gaps":["How RPA is initially kept off versus replaced over the cell cycle unaddressed","TRF2 contribution to loading vs protection partially separable"]},{"year":2010,"claim":"Dissected the kinetic mechanism of telomerase stimulation, showing POT1-TPP1 acts substoichiometrically by slowing primer dissociation and enhancing translocation.","evidence":"In vitro telomerase processivity assays with purified POT1-TPP1 and kinetic step analysis","pmids":["20094033"],"confidence":"High","gaps":["Behavior when many POT1-TPP1 coat long overhangs not yet examined","Structural contacts with telomerase unknown"]},{"year":2011,"claim":"Revealed cell-cycle-regulated handoff of telomeric ssDNA from RPA to POT1, orchestrated by TERRA and hnRNPA1, providing temporal control of POT1 loading.","evidence":"Purified protein assays, extract fractionation, RPA/POT1 imaging, TERRA manipulation, plus EM of POT1-TPP1-coated long ssDNA","pmids":["21399625","21596049"],"confidence":"High","gaps":["Upstream signal triggering the switch during the cell cycle not yet defined","Functional role of compacted nucleoprotein structure unclear"]},{"year":2012,"claim":"Characterized the dynamics of POT1 and POT1-TPP1 on G-quadruplex and telomeric DNA, showing stepwise OB-fold unfolding versus TPP1-enabled sliding.","evidence":"Single-molecule FRET imaging","pmids":["22981946"],"confidence":"Medium","gaps":["Single-lab smFRET not independently corroborated","Physiological relevance of sliding in vivo unestablished"]},{"year":2014,"claim":"Established TIN2 as the stabilizing tether that maintains TPP1/POT1 on telomeric ssDNA, and showed TIN2-tethered TPP1/POT1 is sufficient for end protection independent of TRF1.","evidence":"Conditional knockouts (TIN2, TRF1, BLM, TPP1), TIN2 allele engineering (L247E fusion), epistasis, ATR signaling assays","pmids":["22099311","24469404","25344324"],"confidence":"High","gaps":["How phosphorylation of POT1 or partners modulates tethering unaddressed","Direct structural contacts within the subcomplex unresolved"]},{"year":2015,"claim":"Identified DNA-PKcs phosphorylation of hnRNP-A1 as the kinase signal driving the RPA-to-POT1 switch during G2/M, connecting cell-cycle kinase activity to telomere protection.","evidence":"Kinase assays, phospho-mutant expression, RPA/POT1 co-localization, DDR foci assays","pmids":["25999341"],"confidence":"Medium","gaps":["Single-lab study without independent confirmation","Generality across cell types not established"]},{"year":2016,"claim":"Defined POT1's role in C-strand maintenance via CST and established disease mechanisms—linking the Coats plus S322L mutation and cancer OB-fold mutations to telomere fill-in failure and chromosome fusions.","evidence":"Patient and cancer mutation functional characterization, overhang/FISH assays, A-NHEJ assays, conditional KO mouse cancer models, CST/ATR epistasis","pmids":["27013236","27239034","27869160"],"confidence":"High","gaps":["Direct structural basis of POT1-CST recruitment not yet resolved","How phosphorylation governs CST function unaddressed"]},{"year":2017,"claim":"Resolved the C-terminal POT1 architecture (third OB fold + HJRL domain) and the elongated POT1-TPP1 conformation, explaining how cancer mutations destabilize the complex.","evidence":"Two independent crystal structures of POT1C-TPP1 with biochemical binding and cancer-mutation characterization","pmids":["28393832","28393830"],"confidence":"High","gaps":["Structure of POT1 bound at the ds-ss junction not yet solved","Telomerase-bound conformation unknown"]},{"year":2019,"claim":"Uncovered length-dependent telomerase inhibition by multi-POT1-TPP1 coating (via His266), TIN2's contribution to processivity, and proteostatic and tethering regulators of POT1 abundance.","evidence":"Hydroxyl-radical footprinting/MS with H266L mutant, in vitro telomerase assays with TIN2/TPP1/POT1, ubiquitination/Co-IP for TSPYL5-USP7, and SerRS pulldown/ChIP","pmids":["31685617","31383750","31278054","31815007"],"confidence":"Medium","gaps":["His266 conformational switch from single-lab footprinting only","SerRS-POT1 tethering is Low-confidence and not independently confirmed","ALT-specific POT1 degradation pathway not generalized"]},{"year":2020,"claim":"Defined HDR suppression as a core human POT1 function and characterized replication-stress phenotypes, including G-quadruplex resolution by conformational selection and nuclear repositioning of dysfunctional telomeres.","evidence":"CRISPR conditional deletion in HEK293E with HDR epistasis and proteomics, biophysical G-quadruplex kinetics, BioID and nuclear F-actin imaging in POT1-mutant cells","pmids":["33073402","32232414","33122293"],"confidence":"High","gaps":["Which HDR factors POT1 directly restrains not fully mapped","Trigger for nuclear-periphery relocalization mechanism incomplete"]},{"year":2021,"claim":"Distinguished the cancer-relevant consequence of POT1 mutation as telomere elongation without overt DDR, and assigned the telomerase-recruitment-enhancing role specifically to mouse POT1b.","evidence":"CRISPR engineering of caPOT1 mutations in hESCs/HSCs with in vivo competition, conditional mouse KO with POT1a/b swap and point-mutant complementation","pmids":["33934394","34535663"],"confidence":"High","gaps":["How the three POT1b C-terminal residues mechanistically enhance recruitment not structurally defined","Human single-gene reconciliation of split paralog roles incomplete"]},{"year":2022,"claim":"Provided the structural mechanism of telomerase recruitment, showing how TPP1-POT1 stabilizes telomeric DNA in the active site and defines a DNA exit/anchor path governing processivity.","evidence":"Cryo-EM of human telomerase bound to TPP1 (3.2 Å) and TPP1-POT1 (3.9 Å)","pmids":["35201900"],"confidence":"High","gaps":["Dynamics of recruitment versus the inhibitory 3'-terminal state not captured","How length-dependent inhibition integrates with this structure unclear"]},{"year":2023,"claim":"Solved how POT1 caps the ds-ss junction through a 'POT-hole' surface recognizing the phosphorylated 5' end, explaining 5'-end sequence definition and paralog divergence (POT1a contains it).","evidence":"Crystal structures of the POT1-junction complex with POT-hole mutagenesis and cellular ATR/end-structure assays","pmids":["37590346"],"confidence":"High","gaps":["How junction capping coordinates with overhang coating in vivo unresolved","Regulation of POT-hole engagement across the cell cycle unknown"]},{"year":2024,"claim":"Defined the POT1 phospho-switch that controls CST-Polα/primase: phosphorylated POT1 holds CST inactive, and dephosphorylation releases it for C-strand fill-in synthesis.","evidence":"Cryo-EM of CST-POT1/TPP1 with phosphorylation-dependent interaction and telomere fill-in assays, disease mutation characterization","pmids":["38838667"],"confidence":"High","gaps":["Identity of kinase/phosphatase governing the POT1 hinge switch not established","Temporal coordination with G-strand synthesis unresolved"]},{"year":null,"claim":"The upstream signaling that times POT1 phosphorylation/dephosphorylation and integrates G-quadruplex resolution, junction capping, telomerase regulation, and CST fill-in into one cell-cycle program remains undefined.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No identified enzyme controlling the POT1 hinge phospho-switch","No unified model linking the cap, telomerase, and fill-in functions across the cell cycle","Human reconciliation of the split mouse POT1a/POT1b functions incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,5,6,23,46]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10,16,25,36,44]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[7,8,47]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,12]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[0,12,46]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[17,41,34]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[29,33,47]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[12,14]}],"complexes":["shelterin","POT1-TPP1 heterodimer"],"partners":["TPP1","TIN2","TRF1","TRF2","WRN","BLM","CTC1-STN1-TEN1 (CST)","TSPYL5"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9NUX5","full_name":"Protection of telomeres protein 1","aliases":["POT1-like telomere end-binding protein"],"length_aa":634,"mass_kda":71.4,"function":"Component of the telomerase ribonucleoprotein (RNP) complex that is essential for the replication of chromosome termini. Is a component of the double-stranded telomeric DNA-binding TRF1 complex which is involved in the regulation of telomere length by cis-inhibition of telomerase. Also acts as a single-stranded telomeric DNA-binding protein and thus may act as a downstream effector of the TRF1 complex and may transduce information about telomere maintenance and/or length to the telomere terminus. Component of the shelterin complex (telosome) that is involved in the regulation of telomere length and protection. Shelterin associates with arrays of double-stranded TTAGGG repeats added by telomerase and protects chromosome ends; without its protective activity, telomeres are no longer hidden from the DNA damage surveillance and chromosome ends are inappropriately processed by DNA repair pathways. Binds to two or more telomeric single-stranded 5'-TTAGGG-3' repeats (G-strand) and with high specificity to a minimal telomeric single-stranded 5'-TAGGGTTAG-3' sequence. Binds telomeric single-stranded sequences internally or at proximity of a 3'-end. Its activity is TERT dependent but it does not increase TERT activity by itself. In contrast, the ACD-POT1 heterodimer enhances telomere elongation by increasing telomerase processivity","subcellular_location":"Nucleus; Chromosome, telomere","url":"https://www.uniprot.org/uniprotkb/Q9NUX5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POT1","classification":"Not Classified","n_dependent_lines":537,"n_total_lines":1208,"dependency_fraction":0.4445364238410596},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000128513","cell_line_id":"CID001728","localizations":[{"compartment":"nuclear_punctae","grade":3}],"interactors":[{"gene":"TINF2","stoichiometry":4.0},{"gene":"EIF5","stoichiometry":0.2},{"gene":"TERF2","stoichiometry":0.2},{"gene":"PRKCD","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID001728","total_profiled":1310},"omim":[{"mim_id":"620368","title":"CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 3; CRMCC3","url":"https://www.omim.org/entry/620368"},{"mim_id":"620367","title":"PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE SYNDROME, TELOMERE-RELATED, 8; PFBMFT8","url":"https://www.omim.org/entry/620367"},{"mim_id":"618576","title":"ZINC FINGER- AND BTB DOMAIN-CONTAINING PROTEIN 10; ZBTB10","url":"https://www.omim.org/entry/618576"},{"mim_id":"618030","title":"SHIELD COMPLEX, SUBUNIT 3; SHLD3","url":"https://www.omim.org/entry/618030"},{"mim_id":"618029","title":"SHIELD COMPLEX, SUBUNIT 2; SHLD2","url":"https://www.omim.org/entry/618029"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POT1"},"hgnc":{"alias_symbol":["hPot1","DKFZp586D211"],"prev_symbol":[]},"alphafold":{"accession":"Q9NUX5","domains":[{"cath_id":"2.40.50.140","chopping":"20-142","consensus_level":"high","plddt":93.2747,"start":20,"end":142},{"cath_id":"2.40.50.140","chopping":"149-299","consensus_level":"high","plddt":87.3305,"start":149,"end":299},{"cath_id":"2.40.50.140","chopping":"334-376_539-632","consensus_level":"high","plddt":88.3263,"start":334,"end":632},{"cath_id":"-","chopping":"389-537","consensus_level":"high","plddt":95.2281,"start":389,"end":537}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NUX5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NUX5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NUX5-F1-predicted_aligned_error_v6.png","plddt_mean":87.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POT1","jax_strain_url":"https://www.jax.org/strain/search?query=POT1"},"sequence":{"accession":"Q9NUX5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NUX5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NUX5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NUX5"}},"corpus_meta":[{"pmid":"11349150","id":"PMC_11349150","title":"Pot1, the putative telomere end-binding protein in fission yeast and humans.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11349150","citation_count":815,"is_preprint":false},{"pmid":"17687332","id":"PMC_17687332","title":"Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17687332","citation_count":705,"is_preprint":false},{"pmid":"17237768","id":"PMC_17237768","title":"The POT1-TPP1 telomere complex is a telomerase processivity factor.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17237768","citation_count":561,"is_preprint":false},{"pmid":"12768206","id":"PMC_12768206","title":"POT1 as a terminal transducer of TRF1 telomere length control.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12768206","citation_count":550,"is_preprint":false},{"pmid":"17237767","id":"PMC_17237767","title":"TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase.","date":"2007","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/17237767","citation_count":390,"is_preprint":false},{"pmid":"15558049","id":"PMC_15558049","title":"Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection.","date":"2004","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15558049","citation_count":384,"is_preprint":false},{"pmid":"15231715","id":"PMC_15231715","title":"POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex.","date":"2004","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/15231715","citation_count":354,"is_preprint":false},{"pmid":"15181449","id":"PMC_15181449","title":"PTOP interacts with POT1 and regulates its localization to telomeres.","date":"2004","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15181449","citation_count":350,"is_preprint":false},{"pmid":"16839876","id":"PMC_16839876","title":"Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16839876","citation_count":332,"is_preprint":false},{"pmid":"16839877","id":"PMC_16839877","title":"Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16839877","citation_count":320,"is_preprint":false},{"pmid":"24686849","id":"PMC_24686849","title":"POT1 loss-of-function variants predispose to familial melanoma.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24686849","citation_count":319,"is_preprint":false},{"pmid":"16043710","id":"PMC_16043710","title":"Human POT1 disrupts telomeric G-quadruplexes allowing telomerase extension in vitro.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16043710","citation_count":315,"is_preprint":false},{"pmid":"19854130","id":"PMC_19854130","title":"RPA-like mammalian Ctc1-Stn1-Ten1 complex binds to single-stranded DNA and protects telomeres independently of the Pot1 pathway.","date":"2009","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/19854130","citation_count":286,"is_preprint":false},{"pmid":"21399625","id":"PMC_21399625","title":"TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric single-stranded DNA.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21399625","citation_count":282,"is_preprint":false},{"pmid":"24686846","id":"PMC_24686846","title":"Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24686846","citation_count":278,"is_preprint":false},{"pmid":"15973431","id":"PMC_15973431","title":"POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/15973431","citation_count":241,"is_preprint":false},{"pmid":"23502782","id":"PMC_23502782","title":"POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23502782","citation_count":232,"is_preprint":false},{"pmid":"22099311","id":"PMC_22099311","title":"Telomere protection by TPP1/POT1 requires tethering to TIN2.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22099311","citation_count":189,"is_preprint":false},{"pmid":"18535244","id":"PMC_18535244","title":"Fission yeast Pot1-Tpp1 protects telomeres and regulates telomere length.","date":"2008","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/18535244","citation_count":186,"is_preprint":false},{"pmid":"12781132","id":"PMC_12781132","title":"Human POT1 facilitates telomere elongation by telomerase.","date":"2003","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/12781132","citation_count":170,"is_preprint":false},{"pmid":"16849533","id":"PMC_16849533","title":"The G-quadruplex ligand telomestatin inhibits POT1 binding to telomeric sequences in vitro and induces GFP-POT1 dissociation from telomeres in human cells.","date":"2006","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/16849533","citation_count":170,"is_preprint":false},{"pmid":"14614509","id":"PMC_14614509","title":"DNA self-recognition in the structure of Pot1 bound to telomeric single-stranded DNA.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/14614509","citation_count":168,"is_preprint":false},{"pmid":"15632080","id":"PMC_15632080","title":"Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15632080","citation_count":161,"is_preprint":false},{"pmid":"16030011","id":"PMC_16030011","title":"POT1 stimulates RecQ helicases WRN and BLM to unwind telomeric DNA substrates.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16030011","citation_count":157,"is_preprint":false},{"pmid":"25344324","id":"PMC_25344324","title":"TRF1 negotiates TTAGGG repeat-associated replication problems by recruiting the BLM helicase and the TPP1/POT1 repressor of ATR signaling.","date":"2014","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/25344324","citation_count":156,"is_preprint":false},{"pmid":"17632522","id":"PMC_17632522","title":"Telomere protection by mammalian Pot1 requires interaction with Tpp1.","date":"2007","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17632522","citation_count":152,"is_preprint":false},{"pmid":"20094033","id":"PMC_20094033","title":"POT1-TPP1 enhances telomerase processivity by slowing primer dissociation and aiding translocation.","date":"2010","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/20094033","citation_count":144,"is_preprint":false},{"pmid":"12391173","id":"PMC_12391173","title":"Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing.","date":"2002","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12391173","citation_count":141,"is_preprint":false},{"pmid":"26403419","id":"PMC_26403419","title":"A mutation in the POT1 gene is responsible for cardiac angiosarcoma in TP53-negative Li-Fraumeni-like families.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26403419","citation_count":139,"is_preprint":false},{"pmid":"15792951","id":"PMC_15792951","title":"Switching human telomerase on and off with hPOT1 protein in vitro.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15792951","citation_count":135,"is_preprint":false},{"pmid":"15657433","id":"PMC_15657433","title":"POT1 and TRF2 cooperate to maintain telomeric integrity.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15657433","citation_count":131,"is_preprint":false},{"pmid":"14715659","id":"PMC_14715659","title":"DNA binding features of human POT1: a nonamer 5'-TAGGGTTAG-3' minimal binding site, sequence specificity, and internal binding to multimeric sites.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14715659","citation_count":131,"is_preprint":false},{"pmid":"15620654","id":"PMC_15620654","title":"Loss of hPot1 function leads to telomere instability and a cut-like phenotype.","date":"2004","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/15620654","citation_count":119,"is_preprint":false},{"pmid":"22981946","id":"PMC_22981946","title":"POT1-TPP1 regulates telomeric overhang structural dynamics.","date":"2012","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/22981946","citation_count":108,"is_preprint":false},{"pmid":"27226433","id":"PMC_27226433","title":"Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy.","date":"2016","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/27226433","citation_count":104,"is_preprint":false},{"pmid":"18955498","id":"PMC_18955498","title":"Functional dissection of human and mouse POT1 proteins.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18955498","citation_count":101,"is_preprint":false},{"pmid":"27239034","id":"PMC_27239034","title":"Telomere Replication Stress Induced by POT1 Inactivation Accelerates Tumorigenesis.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27239034","citation_count":98,"is_preprint":false},{"pmid":"14744765","id":"PMC_14744765","title":"Expression of POT1 is associated with tumor stage and telomere length in gastric carcinoma.","date":"2004","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/14744765","citation_count":93,"is_preprint":false},{"pmid":"28393830","id":"PMC_28393830","title":"Structural and functional analysis of the human POT1-TPP1 telomeric complex.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28393830","citation_count":86,"is_preprint":false},{"pmid":"27013236","id":"PMC_27013236","title":"A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus.","date":"2016","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/27013236","citation_count":86,"is_preprint":false},{"pmid":"28393832","id":"PMC_28393832","title":"Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28393832","citation_count":82,"is_preprint":false},{"pmid":"35201900","id":"PMC_35201900","title":"Structural basis of human telomerase recruitment by TPP1-POT1.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35201900","citation_count":80,"is_preprint":false},{"pmid":"12463756","id":"PMC_12463756","title":"Cooperative binding of single-stranded telomeric DNA by the Pot1 protein of Schizosaccharomyces pombe.","date":"2002","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12463756","citation_count":75,"is_preprint":false},{"pmid":"21183684","id":"PMC_21183684","title":"Single molecule studies of physiologically relevant telomeric tails reveal POT1 mechanism for promoting G-quadruplex unfolding.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21183684","citation_count":75,"is_preprint":false},{"pmid":"28853721","id":"PMC_28853721","title":"The wide spectrum of POT1 gene variants correlates with multiple cancer types.","date":"2017","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/28853721","citation_count":69,"is_preprint":false},{"pmid":"24469404","id":"PMC_24469404","title":"TRF2-tethered TIN2 can mediate telomere protection by TPP1/POT1.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24469404","citation_count":68,"is_preprint":false},{"pmid":"15060173","id":"PMC_15060173","title":"Rescue of an hTERT mutant defective in telomere elongation by fusion with hPot1.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15060173","citation_count":64,"is_preprint":false},{"pmid":"16943437","id":"PMC_16943437","title":"Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection.","date":"2006","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16943437","citation_count":59,"is_preprint":false},{"pmid":"20493859","id":"PMC_20493859","title":"Pot1 and telomere maintenance.","date":"2010","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/20493859","citation_count":57,"is_preprint":false},{"pmid":"18066078","id":"PMC_18066078","title":"Pot1 and cell cycle progression cooperate in telomere length regulation.","date":"2007","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18066078","citation_count":54,"is_preprint":false},{"pmid":"25999341","id":"PMC_25999341","title":"DNA-PKcs phosphorylates hnRNP-A1 to facilitate the RPA-to-POT1 switch and telomere capping after replication.","date":"2015","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/25999341","citation_count":54,"is_preprint":false},{"pmid":"20080730","id":"PMC_20080730","title":"How telomeric protein POT1 avoids RNA to achieve specificity for single-stranded DNA.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/20080730","citation_count":52,"is_preprint":false},{"pmid":"33122293","id":"PMC_33122293","title":"Replication stress conferred by POT1 dysfunction promotes telomere relocalization to the nuclear pore.","date":"2020","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/33122293","citation_count":52,"is_preprint":false},{"pmid":"32987645","id":"PMC_32987645","title":"Role of POT1 in Human Cancer.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32987645","citation_count":51,"is_preprint":false},{"pmid":"27869160","id":"PMC_27869160","title":"Pot1 OB-fold mutations unleash telomere instability to initiate tumorigenesis.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/27869160","citation_count":51,"is_preprint":false},{"pmid":"20811636","id":"PMC_20811636","title":"The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20811636","citation_count":51,"is_preprint":false},{"pmid":"20008939","id":"PMC_20008939","title":"Human POT1 is required for efficient telomere C-rich strand replication in the absence of WRN.","date":"2009","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/20008939","citation_count":49,"is_preprint":false},{"pmid":"23619786","id":"PMC_23619786","title":"Cancer chromosomes going to POT1.","date":"2013","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23619786","citation_count":49,"is_preprint":false},{"pmid":"33934394","id":"PMC_33934394","title":"Cancer-associated POT1 mutations lead to telomere elongation without induction of a DNA damage response.","date":"2021","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33934394","citation_count":47,"is_preprint":false},{"pmid":"31278054","id":"PMC_31278054","title":"TSPYL5 Depletion Induces Specific Death of ALT Cells through USP7-Dependent Proteasomal Degradation of POT1.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/31278054","citation_count":47,"is_preprint":false},{"pmid":"19734539","id":"PMC_19734539","title":"Telomeric D-loops containing 8-oxo-2'-deoxyguanosine are preferred substrates for Werner and Bloom syndrome helicases and are bound by POT1.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19734539","citation_count":46,"is_preprint":false},{"pmid":"31937561","id":"PMC_31937561","title":"POT1 mutation spectrum in tumour types commonly diagnosed among POT1-associated hereditary cancer syndrome families.","date":"2020","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31937561","citation_count":44,"is_preprint":false},{"pmid":"33073402","id":"PMC_33073402","title":"Human shelterin protein POT1 prevents severe telomere instability induced by homology-directed DNA repair.","date":"2020","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33073402","citation_count":43,"is_preprint":false},{"pmid":"32774788","id":"PMC_32774788","title":"POT1-TPP1 telomere length regulation and disease.","date":"2020","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/32774788","citation_count":42,"is_preprint":false},{"pmid":"31383750","id":"PMC_31383750","title":"TIN2 Functions with TPP1/POT1 To Stimulate Telomerase Processivity.","date":"2019","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/31383750","citation_count":42,"is_preprint":false},{"pmid":"15964812","id":"PMC_15964812","title":"Distinct requirements for Pot1 in limiting telomere length and maintaining chromosome stability.","date":"2005","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15964812","citation_count":42,"is_preprint":false},{"pmid":"30451293","id":"PMC_30451293","title":"POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.","date":"2019","source":"The British journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30451293","citation_count":42,"is_preprint":false},{"pmid":"32492864","id":"PMC_32492864","title":"A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32492864","citation_count":39,"is_preprint":false},{"pmid":"24297748","id":"PMC_24297748","title":"The shelterin protein POT-1 anchors Caenorhabditis elegans telomeres through SUN-1 at the nuclear periphery.","date":"2013","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24297748","citation_count":37,"is_preprint":false},{"pmid":"28389767","id":"PMC_28389767","title":"A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.","date":"2017","source":"Familial cancer","url":"https://pubmed.ncbi.nlm.nih.gov/28389767","citation_count":36,"is_preprint":false},{"pmid":"30586141","id":"PMC_30586141","title":"Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.","date":"2019","source":"JAMA dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/30586141","citation_count":36,"is_preprint":false},{"pmid":"37590346","id":"PMC_37590346","title":"Human POT1 protects the telomeric ds-ss DNA junction by capping the 5' end of the chromosome.","date":"2023","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/37590346","citation_count":35,"is_preprint":false},{"pmid":"34535663","id":"PMC_34535663","title":"Distinct functions of POT1 proteins contribute to the regulation of telomerase recruitment to telomeres.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34535663","citation_count":35,"is_preprint":false},{"pmid":"21596049","id":"PMC_21596049","title":"Multiple POT1-TPP1 proteins coat and compact long telomeric single-stranded DNA.","date":"2011","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21596049","citation_count":34,"is_preprint":false},{"pmid":"32325837","id":"PMC_32325837","title":"Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32325837","citation_count":34,"is_preprint":false},{"pmid":"18519588","id":"PMC_18519588","title":"Distinct functions of POT1 at telomeres.","date":"2008","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18519588","citation_count":32,"is_preprint":false},{"pmid":"35420632","id":"PMC_35420632","title":"Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis.","date":"2022","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35420632","citation_count":31,"is_preprint":false},{"pmid":"20601686","id":"PMC_20601686","title":"Pot1 inactivation leads to rampant telomere resection and loss in one cell cycle.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20601686","citation_count":31,"is_preprint":false},{"pmid":"32232414","id":"PMC_32232414","title":"Human POT1 unfolds G-quadruplexes by conformational selection.","date":"2020","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/32232414","citation_count":30,"is_preprint":false},{"pmid":"18583366","id":"PMC_18583366","title":"Mechanism and substrate specificity of telomeric protein POT1 stimulation of the Werner syndrome helicase.","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18583366","citation_count":30,"is_preprint":false},{"pmid":"19783822","id":"PMC_19783822","title":"POT1 proteins in green algae and land plants: DNA-binding properties and evidence of co-evolution with telomeric DNA.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19783822","citation_count":30,"is_preprint":false},{"pmid":"18492102","id":"PMC_18492102","title":"Splenic marginal zone lymphomas are characterized by loss of interstitial regions of chromosome 7q, 7q31.32 and 7q36.2 that include the protection of telomere 1 (POT1) and sonic hedgehog (SHH) genes.","date":"2008","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/18492102","citation_count":29,"is_preprint":false},{"pmid":"19651898","id":"PMC_19651898","title":"POT1 association with TRF2 regulates telomere length.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19651898","citation_count":26,"is_preprint":false},{"pmid":"22373525","id":"PMC_22373525","title":"RPA and POT1: friends or foes at telomeres?","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/22373525","citation_count":25,"is_preprint":false},{"pmid":"31685617","id":"PMC_31685617","title":"POT1-TPP1 differentially regulates telomerase via POT1 His266 and as a function of single-stranded telomere DNA length.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31685617","citation_count":25,"is_preprint":false},{"pmid":"19228335","id":"PMC_19228335","title":"POT1-independent single-strand telomeric DNA binding activities in Brassicaceae.","date":"2009","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19228335","citation_count":25,"is_preprint":false},{"pmid":"1354832","id":"PMC_1354832","title":"The POT1 gene for yeast peroxisomal thiolase is subject to three different mechanisms of regulation.","date":"1992","source":"Molecular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/1354832","citation_count":25,"is_preprint":false},{"pmid":"38838667","id":"PMC_38838667","title":"POT1 recruits and regulates CST-Polα/primase at human telomeres.","date":"2024","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/38838667","citation_count":24,"is_preprint":false},{"pmid":"28986560","id":"PMC_28986560","title":"The telomere binding protein Pot1 maintains haematopoietic stem cell activity with age.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28986560","citation_count":24,"is_preprint":false},{"pmid":"32687062","id":"PMC_32687062","title":"MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32687062","citation_count":24,"is_preprint":false},{"pmid":"31815007","id":"PMC_31815007","title":"Seryl tRNA synthetase cooperates with POT1 to regulate telomere length and cellular senescence.","date":"2019","source":"Signal transduction and targeted therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31815007","citation_count":24,"is_preprint":false},{"pmid":"32040538","id":"PMC_32040538","title":"Genetic variation in POT1 and risk of thyroid subsequent malignant neoplasm: A report from the Childhood Cancer Survivor Study.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32040538","citation_count":24,"is_preprint":false},{"pmid":"21911358","id":"PMC_21911358","title":"DNA-induced dimerization of the single-stranded DNA binding telomeric protein Pot1 from Schizosaccharomyces pombe.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/21911358","citation_count":23,"is_preprint":false},{"pmid":"23390606","id":"PMC_23390606","title":"Caenorhabditis elegans POT-1 and POT-2 repress telomere maintenance pathways.","date":"2013","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23390606","citation_count":23,"is_preprint":false},{"pmid":"27173378","id":"PMC_27173378","title":"POT1-TPP1 Binding and Unfolding of Telomere DNA Discriminates against Structural Polymorphism.","date":"2016","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/27173378","citation_count":22,"is_preprint":false},{"pmid":"20061197","id":"PMC_20061197","title":"Altered mRNA expression of telomere binding proteins (TPP1, POT1, RAP1, TRF1 and TRF2) in ulcerative colitis and Crohn's disease.","date":"2010","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/20061197","citation_count":21,"is_preprint":false},{"pmid":"28922845","id":"PMC_28922845","title":"POT1-mediated δ-integration strategy for high-copy, stable expression of heterologous proteins in Saccharomyces cerevisiae.","date":"2017","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/28922845","citation_count":21,"is_preprint":false},{"pmid":"22369941","id":"PMC_22369941","title":"Interaction of Berberine derivative with protein POT1 affect telomere function in cancer cells.","date":"2012","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/22369941","citation_count":19,"is_preprint":false},{"pmid":"37183325","id":"PMC_37183325","title":"POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes.","date":"2023","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/37183325","citation_count":18,"is_preprint":false},{"pmid":"29523635","id":"PMC_29523635","title":"Germline Variants in the POT1-Gene in High-Risk Melanoma Patients in Austria.","date":"2018","source":"G3 (Bethesda, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/29523635","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43068,"output_tokens":10973,"usd":0.146899,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":21727,"output_tokens":6991,"usd":0.141705,"stage2_stop_reason":"end_turn"},"total_usd":0.288604,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"POT1 (protection of telomeres 1) protein binds the single-stranded G-rich telomeric DNA overhang at chromosome ends. Deletion of fission yeast pot1+ causes rapid loss of telomeric DNA and chromosome circularization, establishing a direct role in chromosome end protection.\",\n      \"method\": \"Genetic deletion in S. pombe (pot1+ knockout), in vitro DNA binding assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — direct binding demonstrated in vitro, genetic deletion with clear chromosomal phenotype, foundational paper widely replicated\",\n      \"pmids\": [\"11349150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Crystal structure of the N-terminal DNA-binding domain of S. pombe Pot1p complexed with single-stranded telomeric DNA at 1.9 Å resolution. The protein adopts an OB fold with two loops forming a clamp; sequence specificity arises from DNA self-recognition involving base-stacking and unusual G-T base pairs.\",\n      \"method\": \"X-ray crystallography at 1.9 Å resolution\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution crystal structure with functional validation of sequence specificity\",\n      \"pmids\": [\"14614509\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Human POT1 acts as a positive regulator of telomere length in a telomerase-dependent manner. Overexpression of hPOT1 splice variants lengthened telomeres only in telomerase-positive cells, indicating POT1 facilitates telomerase-mediated elongation.\",\n      \"method\": \"Overexpression of POT1 splice variants in telomerase-positive vs. telomerase-negative cell lines, telomere length analysis\",\n      \"journal\": \"Current Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — functional overexpression with telomerase-dependence control, single lab\",\n      \"pmids\": [\"12781132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"POT1 interacts with the TRF1 complex, and its binding to telomeres is regulated by TRF1 in response to telomere length. A POT1 mutant lacking the DNA-binding domain (acting as dominant negative) abrogates TRF1-mediated telomere length control and induces rapid telomere elongation, identifying POT1 as a terminal transducer of TRF1 telomere length signaling.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative POT1 expression, telomere length assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP, dominant-negative genetics, replicated by multiple labs\",\n      \"pmids\": [\"12768206\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Epitope-tagged human POT1 localizes to telomeres in interphase nuclei as shown by indirect immunofluorescence. Multiple splice variants of hPOT1 exist and differ in their ability to form complexes with single-stranded telomeric DNA.\",\n      \"method\": \"Indirect immunofluorescence (EMSA for splice variant DNA binding)\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — direct localization by immunofluorescence, EMSA for DNA binding, single lab\",\n      \"pmids\": [\"12391173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Crystal structure of the N-terminal half of human POT1 bound to the telomeric ssDNA decamer TTAGGGTTAG at 1.73 Å resolution. hPOT1 contains two OB folds: the first binds the first six nucleotides, while the second OB fold binds and protects the 3' end of the ssDNA.\",\n      \"method\": \"X-ray crystallography at 1.73 Å resolution with in vitro binding assays\",\n      \"journal\": \"Nature Structural & Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — high-resolution crystal structure with in vitro binding validation\",\n      \"pmids\": [\"15558049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The minimal binding site for human POT1 on telomeric ssDNA is the nonamer 5'-TAGGGTTAG-3'. Deletion of the OB fold abolishes DNA binding. POT1 can bind internally to multimeric [TTAGGG]n arrays as well as at 3' ends.\",\n      \"method\": \"In vitro binding assays (EMSA, deletion and substitution mutants)\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro binding with mutagenesis, well-defined minimal binding site\",\n      \"pmids\": [\"14715659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"A novel telomeric protein PIP1 (also identified as PTOP/TPP1) binds both POT1 and TIN2, tethering POT1 to the TRF1 complex. ShRNA depletion of PIP1 or POT1 causes telomere elongation, indicating PIP1 contributes to telomere length control through POT1 recruitment.\",\n      \"method\": \"Mass spectrometry identification, co-immunoprecipitation, shRNA knockdown, telomere length assays\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — MS identification, Co-IP, functional knockdown with defined phenotype, replicated independently\",\n      \"pmids\": [\"15231715\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PTOP (also called PIP1/TPP1) interacts with the C-terminus of POT1 and recruits it to telomeres. RNAi-mediated inhibition of PTOP or disruption of the PTOP-POT1 interaction prevents POT1 telomeric localization and extends telomere length.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown, fluorescence imaging, telomere length assays\",\n      \"journal\": \"Nature Cell Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, RNAi with functional phenotype, direct localization experiment, independently replicated\",\n      \"pmids\": [\"15181449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"hPOT1 disrupts telomeric G-quadruplex structures by forming a stoichiometric complex with the DNA (not catalytically), freeing the 3' tail and restoring processive telomerase elongation of G-quadruplex primers in vitro.\",\n      \"method\": \"In vitro telomerase extension assay, gel mobility shift assay with purified recombinant hPOT1\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro assay with purified proteins, stoichiometry established\",\n      \"pmids\": [\"16043710\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Human POT1 acts as a negative regulator of telomerase in vitro through its DNA-binding activity. POT1 bound at the extreme 3' end of the telomere blocks telomerase, but when bound one repeat before the 3' end (leaving an 8-nt tail), it creates a preferred substrate for telomerase with improved activity and processivity.\",\n      \"method\": \"In vitro telomerase extension assay with recombinant hPOT1, crystal-structure guided positioning experiments\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro assay with mutagenesis and structural basis, multiple conditions tested\",\n      \"pmids\": [\"15792951\", \"15632080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"POT1 stimulates WRN and BLM RecQ helicases to unwind long telomeric forked duplexes and D-loop structures. This stimulation requires telomeric sequence in the duplex regions. Purified POT1 directly binds WRN and BLM in vitro.\",\n      \"method\": \"In vitro helicase assay with purified proteins, pulldown assay for protein-protein interaction\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro helicase assay plus direct pulldown binding, multiple substrates tested\",\n      \"pmids\": [\"16030011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"RNAi-mediated depletion of POT1 in human cells reduces the telomeric 3' overhang DNA and induces a transient DNA damage response at all telomeres in G1, but does not cause telomere fusions or cell cycle arrest. POT1 also determines the correct sequence at chromosome ends: normally the recessed 5' end ends on ATC-5', and this positional specificity is lost upon POT1 depletion.\",\n      \"method\": \"RNAi knockdown, telomere overhang assay, fluorescence imaging of DNA damage foci, telomere sequencing\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — RNAi with multiple orthogonal readouts (overhang assay, DDR foci, sequence analysis), specific mechanistic conclusions\",\n      \"pmids\": [\"15973431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"POT1 and TRF2 interact to form a complex with telomeric DNA. POT1 knockdown causes loss of telomeric single-stranded overhangs, apoptosis, chromosomal instability, and senescence. POT1 overexpression partially rescues TRF2-dominant-negative-induced telomere dysfunction.\",\n      \"method\": \"Co-immunoprecipitation, RNAi knockdown, overexpression rescue experiments, telomere overhang assay\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP for protein interaction, RNAi phenotype with rescue, single lab\",\n      \"pmids\": [\"15657433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Conditional deletion of mouse Pot1a activates a DNA damage response at telomeres, causing p53-dependent replicative senescence. Pot1a-deficient cells show overall telomere length and 3' overhang elongation and aberrant homologous recombination (telomere sister chromatid exchanges and telomere circle formation) that requires NBS1.\",\n      \"method\": \"Conditional knockout in mouse cells, genetic epistasis (NBS1 requirement), telomere FISH, telomere overhang assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple phenotypic readouts plus epistasis (NBS1), replicated independently\",\n      \"pmids\": [\"16839876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Mouse telomeres contain two POT1 paralogs with distinct functions: POT1a represses a DNA damage signal at telomeres, while POT1b regulates the amount of single-stranded DNA at the telomere terminus. Double knockout causes a DNA damage signal, endoreduplication, and senescence.\",\n      \"method\": \"Conditional deletion of POT1a and/or POT1b in mouse cells, complementation experiments, telomere overhang and FISH assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO single/double knockouts with complementation, multiple phenotypic readouts, replicated\",\n      \"pmids\": [\"16839877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of the TPP1 OB domain reveals structural similarity to the ciliate TEBP-beta subunit. TPP1 and POT1 form a complex that increases telomerase activity and processivity; TPP1-POT1 on telomeric DNA stimulates the telomerase core enzyme, switching from telomerase inhibition to a processivity factor role.\",\n      \"method\": \"X-ray crystallography of TPP1 OB domain, in vitro telomerase processivity assay with purified POT1-TPP1\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus reconstituted in vitro telomerase assay, independently replicated by two concurrent papers\",\n      \"pmids\": [\"17237768\", \"17237767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"POT1 prevents activation of ATR kinase signaling at telomeres independently of TRF2's repression of ATM. Depletion of POT1 selectively activates ATR (not ATM), while TRF2 depletion selectively activates ATM. These two shelterin proteins act independently in repressing the two DNA damage response pathways.\",\n      \"method\": \"Conditional depletion in ATM-/- and/or ATR-/- cell backgrounds (epistasis), DDR phosphorylation assays\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis across multiple kinase-null backgrounds, replicated independently\",\n      \"pmids\": [\"17687332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Tpp1 (TPP1 homolog in fission yeast) forms a complex with Pot1, which recruits effector molecules Ccq1 and Poz1. Poz1 bridges Pot1-Tpz1 and Taz1-Rap1, connecting single-stranded and double-stranded telomeric DNA regions, analogous to the mammalian shelterin architecture.\",\n      \"method\": \"Co-immunoprecipitation, yeast genetics, protein interaction mapping\",\n      \"journal\": \"Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and genetic analysis in fission yeast, single lab\",\n      \"pmids\": [\"18535244\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The telomere protection function of mammalian Pot1 requires its interaction with Tpp1. Using Tpp1-knockdown cells and Pot1 variants, it was shown that Tpp1 is required for Pot1 to protect chromosome ends (suppress ATR signaling and prevent fusions), not just for telomere length regulation.\",\n      \"method\": \"RNAi knockdown of Tpp1, complementation with POT1 variants, conditional knockouts, telomere dysfunction assays\",\n      \"journal\": \"Nature Structural & Molecular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic approaches, complementation experiments, clear separation-of-function\",\n      \"pmids\": [\"17632522\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Domain-swap and separation-of-function analysis shows that the DNA-binding domain of POT1a specifies its ability to repress the ATR DNA damage response, while POT1b's ability to control 5'-end resection requires the TPP1-binding domain plus a region between amino acids 300–350. Human POT1 combines both functional features. Neither POT1a nor POT1b differs in in vitro DNA binding properties.\",\n      \"method\": \"Domain-swap mutagenesis, complementation of POT1a/b knockout cells, telomere damage assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — systematic domain swapping with functional complementation, multiple phenotypic readouts\",\n      \"pmids\": [\"18955498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"POT1 OB-fold-dependent binding to ssDNA and association with TPP1 are both required in cis for POT1 to protect telomeres and inhibit RPA localization. TRF2 binding by POT1 is dispensable for protection but promotes robust POT1 loading onto telomeric chromatin.\",\n      \"method\": \"Separation-of-function POT1 mutants, fluorescence imaging, RPA co-localization assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple separation-of-function mutants, orthogonal assays, mechanistic conclusion on RPA exclusion\",\n      \"pmids\": [\"18519588\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"TIN2 is required for the telomeric accumulation of TPP1/POT1. Upon TIN2 deletion, telomeres lose TPP1/POT1a, accumulate RPA, and activate ATR signaling. TIN2's major role is to stabilize TPP1/POT1 on ss telomeric DNA to allow RPA exclusion and ATR repression.\",\n      \"method\": \"Conditional knockout of TIN2, telomere protein localization (immunofluorescence), ATR signaling assays\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple mechanistic readouts, epistasis with ATR pathway, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"22099311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"POT1 discriminates ssDNA over RNA via a single deoxythymidine in each telomeric repeat. A Phe62 residue creates a hydrophobic region that buries the 2'-OH of a ribouridine and eliminates favorable hydrogen bonds. TPP1 greatly augments POT1's RNA discrimination. Crystal structure of hPOT1 with a ribouridine-substituted DNA confirms the mechanism.\",\n      \"method\": \"In vitro binding assays, X-ray crystallography of hPOT1 with ribouridine-substituted DNA, site-directed mutagenesis (F62Y)\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus mutagenesis and binding assays, mechanistically detailed\",\n      \"pmids\": [\"20080730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Human POT1 has higher affinity for telomeric G-rich ssDNA than RPA. Under conditions where both WRN and POT1 are limiting, both G- and C-rich telomeric strands shorten. A POT1 OB-fold fragment can restore C-strand (but not G-strand) replication in WRN-depleted cells, suggesting POT1 binding to the lagging strand template enables DNA synthesis uncoupling.\",\n      \"method\": \"RNAi knockdown of WRN and/or POT1, telomere strand-specific assays, in vitro competition binding assays\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — genetic knockdown with strand-specific telomere readouts plus in vitro binding, single lab\",\n      \"pmids\": [\"20008939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"POT1-TPP1 enhances telomerase processivity by (1) slowing primer dissociation rate and (2) increasing translocation efficiency. A single POT1-TPP1-DNA interaction is necessary and sufficient. POT1-TPP1 can function substoichiometrically, supporting a recruitment function.\",\n      \"method\": \"In vitro telomerase processivity assays with purified POT1-TPP1, kinetic analysis of primer dissociation and translocation steps\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro assay dissecting individual kinetic steps, multiple controls including template mutant\",\n      \"pmids\": [\"20094033\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"TERRA and hnRNPA1 orchestrate an RPA-to-POT1 switch on telomeric ssDNA. hnRNPA1 specifically displaces RPA (but not POT1) from telomeric ssDNA. TERRA inhibits this activity in early S phase; TERRA decline in late S phase unleashes hnRNPA1-mediated RPA displacement. TERRA re-accumulation after S phase promotes POT1 binding by removing hnRNPA1.\",\n      \"method\": \"Purified protein assays, cell extract fractionation, fluorescence imaging of RPA/POT1 at telomeres, TERRA manipulation experiments\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reconstitution with purified proteins plus cell-based validation, multiple orthogonal methods\",\n      \"pmids\": [\"21399625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Multiple POT1-TPP1 heterodimers can coat long telomeric ssDNA (72–144 nt), forming compact, potentially ordered nucleoprotein structures. POT1-TPP1 (but not POT1 alone) leads to compaction of the coated ssDNA as visualized by electron microscopy.\",\n      \"method\": \"EMSA, size-exclusion chromatography, transmission electron microscopy\",\n      \"journal\": \"Journal of Molecular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple biochemical methods with structural imaging, single lab\",\n      \"pmids\": [\"21596049\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"POT1 unfolds G-quadruplex DNA in a stepwise, sequential manner (one OB fold at a time, 3' to 5'). In contrast, the POT1-TPP1 complex induces continuous folding and unfolding dynamics and slides back and forth on telomeric DNA, including on mutant telomeric DNA to which POT1 alone cannot bind.\",\n      \"method\": \"Single-molecule FRET (smFRET) imaging\",\n      \"journal\": \"Structure\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — single-molecule real-time imaging with controls, single lab\",\n      \"pmids\": [\"22981946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TRF1 deploys TIN2 and the TPP1/POT1 heterodimers to prevent ATR activation during telomere replication and repress sister telomere associations. BLM facilitates lagging-strand telomeric DNA synthesis downstream of TRF1. These are two mechanistically distinct TRF1 functions in replication.\",\n      \"method\": \"Conditional knockouts (TRF1, BLM, TPP1, Rap1) in mouse cells, epistasis analysis, TRF1/TIN2 mutant expression\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple conditional KOs with epistasis, separation of distinct TRF1 functions, rigorous controls\",\n      \"pmids\": [\"25344324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TIN2-tethered TPP1/POT1 is sufficient for telomere protection even without TRF1 binding; when TIN2 is tethered to telomeres via TRF2 (using an artificial RCT-TIN2-L247E fusion), chromosome end protection by TRF2, TPP1/POT1a, and TPP1/POT1b is fully restored.\",\n      \"method\": \"TIN2 allele engineering (L247E mutation), fusion protein expression, conditional complementation, telomere dysfunction assays\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — engineered mutant alleles with functional complementation, single lab\",\n      \"pmids\": [\"24469404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"DNA-PKcs phosphorylates hnRNP-A1 during G2/M phases to facilitate the RPA-to-POT1 switch on telomeric 3' overhangs. Loss of DNA-PKcs or its phosphorylation of hnRNP-A1 impairs this switch, causing DNA damage responses at telomeres during mitosis and fragile telomeres.\",\n      \"method\": \"Kinase assays, phospho-mutant expression, RPA/POT1 co-localization at telomeres, DNA damage foci assays\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical phosphorylation assay plus cellular imaging with functional consequence, single lab\",\n      \"pmids\": [\"25999341\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A POT1 S322L mutation (POT1-CP) found in Coats plus disease is defective in regulating telomerase (leading to telomere elongation) and in maintenance of the telomeric C strand, causing extended 3' overhangs and stochastic telomere truncations. POT1-CP can bind TPP1 and telomeres and block ATR signaling normally. POT1/CST-dependent telomere fill-in is implicated as the mechanism disrupted in Coats plus.\",\n      \"method\": \"Patient-derived mutation functional characterization, telomere length assays, overhang assays, telomere FISH, telomerase regulation assays, epistasis with telomerase\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal assays on patient mutation, functional separation from other POT1 activities, disease mechanism established\",\n      \"pmids\": [\"27013236\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"POT1 inactivation causes telomere fragility, replication fork stalling, ATR-dependent DNA damage signaling, and telomere elongation. These phenotypes are linked to impaired CST (CTC1-STN1-TEN1) function at telomeres. Cancer cells lacking POT1 function require attenuation of the ATR kinase pathway to proliferate.\",\n      \"method\": \"Conditional murine POT1a depletion in lymphoid progenitors, human/mouse cancer-associated POT1 mutation analysis, telomere replication assays, ATR pathway epistasis\",\n      \"journal\": \"Cell Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic model plus cancer-associated mutations, multiple readouts, single lab\",\n      \"pmids\": [\"27239034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Human POT1 OB-fold mutations found in cancers fail to bind ssDNA, elicit a DNA damage response, and promote chromosome fusions via alternative NHEJ (A-NHEJ). Combined conditional deletion of Pot1a/b and p53 in mouse mammary epithelium produces highly invasive breast carcinomas with telomeric breakage-fusion-bridge cycles.\",\n      \"method\": \"OB-fold mutant expression, telomere FISH, A-NHEJ assays, conditional KO mouse model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple human cancer mutations functionally characterized, mouse conditional KO model, A-NHEJ pathway identified\",\n      \"pmids\": [\"27869160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Crystal structure of the C-terminal portion of human POT1 (POT1C) complexed with the POT1-binding motif of TPP1. POT1C contains a third OB fold and a Holliday junction resolvase-like (HJRL) domain; both domains are essential for TPP1 binding. The POT1-TPP1 complex adopts an elongated V-shaped conformation. Cancer-associated missense mutations in POT1C disrupt the POT1-TPP1 interaction, destabilize POT1, and impair telomeric DNA binding.\",\n      \"method\": \"X-ray crystallography, biochemical binding assays, cancer mutation characterization\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — two independent crystal structures with biochemical validation, replicated in same year by concurrent paper (PMID:28393830)\",\n      \"pmids\": [\"28393832\", \"28393830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"POT1 His266 is a key residue mediating length-dependent regulation of telomerase. When multiple POT1-TPP1 proteins coat physiologically relevant lengths of telomeric ssDNA, they inhibit telomerase. The CLL-associated H266L mutation abrogates this inhibitory function of multi-POT1-TPP1 coating, leading to telomere overextension. Hydroxyl radical footprinting reveals conformational changes around His266 dependent on ssDNA substrate length.\",\n      \"method\": \"Hydroxyl radical footprinting coupled with mass spectrometry, in vitro telomerase assay, binding assays with H266L mutant POT1-TPP1\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — novel biophysical method plus functional assay, single lab, single publication\",\n      \"pmids\": [\"31685617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TSPYL5 prevents poly-ubiquitination and proteasomal degradation of POT1 specifically in ALT+ cancer cells. In the absence of TSPYL5, USP7 deubiquitinase activity activates POT1 E3 ubiquitin ligase(s), promoting POT1 poly-ubiquitination. PML body environment in ALT cells potentiates POT1 degradation.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination assays, siRNA knockdown, proteasome inhibitor experiments\",\n      \"journal\": \"Molecular Cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus ubiquitination assay and siRNA epistasis, single lab\",\n      \"pmids\": [\"31278054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SerRS (seryl tRNA synthetase) directly binds to telomeric DNA repeats in the nucleus and tethers additional POT1 proteins to telomeres through a direct interaction between the UNE-S domain of SerRS and the OB1 domain of POT1. Enrichment of POT1 at telomeres by SerRS prevents telomerase recruitment and causes progressive telomere shortening.\",\n      \"method\": \"Co-immunoprecipitation, pulldown, ChIP, telomere length assays\",\n      \"journal\": \"Signal Transduction and Targeted Therapy\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — Co-IP and pulldown but single lab, single publication, indirect functional readout\",\n      \"pmids\": [\"31815007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"TIN2 stimulates telomerase processivity in vitro, and this stimulation requires a functional TPP1 TEL patch (the telomerase-recruiting surface of TPP1), indicating TIN2 functions with TPP1/POT1 as a functional shelterin subcomplex to stimulate telomerase.\",\n      \"method\": \"In vitro telomerase processivity assay with purified TIN2/TPP1/POT1, TPP1 TEL-patch mutants\",\n      \"journal\": \"Molecular and Cellular Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reconstituted in vitro assay with mutagenesis, single lab\",\n      \"pmids\": [\"31383750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"POT1 unfolds telomeric G-quadruplex structures via a conformational selection mechanism (not induced fit): POT1 binding is coupled to an obligatory prior unfolding of the G-quadruplex. The final complex has 2 POT1 per 24 nt DNA. Binding to folded G-quadruplex is four orders of magnitude slower than to single-stranded DNA.\",\n      \"method\": \"Stopped-flow kinetics, spectroscopic titration, isothermal calorimetry, analytical ultracentrifugation, circular dichroism, molecular dynamics simulation\",\n      \"journal\": \"Nucleic Acids Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biophysical methods with quantitative fitting, single lab but very rigorous\",\n      \"pmids\": [\"32232414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Complete conditional deletion of POT1 in human HEK293E cells causes rapid telomere elongation and length heterogeneity, branched telomeric DNA structures, telomeric R-loops, and telomere fragility. Inactivation of homology-directed repair machinery suppresses these defects, identifying suppression of HDR as a major function of human POT1.\",\n      \"method\": \"Conditional gene deletion (CRISPR-based), telomeric chromatin isolation proteomics, epistasis with HDR pathway inhibitors, telomere FISH\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple orthogonal readouts plus HDR epistasis, proteomics\",\n      \"pmids\": [\"33073402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"POT1 dysfunction (mutations) causes replication stress manifesting as increased mitotic DNA synthesis at telomeres. Depletion of nuclear pore complex (NPC) subunits worsens telomere damage in POT1-mutant cells. Mutant-POT1-expressing cells relocalize dysfunctional telomeres to the nuclear periphery via nuclear F-actin polymerization.\",\n      \"method\": \"CRISPR interference, biotin-based proximity labeling (BioID), nuclear pore subunit depletion, nuclear F-actin imaging\",\n      \"journal\": \"Genes & Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR genetics with proteomics and imaging, single lab\",\n      \"pmids\": [\"33122293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Cancer-associated POT1 mutations engineered into human embryonic stem cells and hematopoietic stem cells cause telomere elongation without detectable telomere damage response or ATR signaling. This indicates caPOT1 mutations are selected in cancer for their ability to elongate telomeres rather than for induction of DNA damage.\",\n      \"method\": \"CRISPR engineering of cancer-associated POT1 mutations in hESCs and HSCs, telomere damage assays, competition experiments in vitro and in vivo\",\n      \"journal\": \"EMBO Journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — precise CRISPR engineering, multiple stem cell types, in vivo competition experiments, clear mechanistic separation\",\n      \"pmids\": [\"33934394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Mouse POT1b (but not POT1a) enhances telomerase recruitment to telomeres through three specific amino acids in its TPP1-interacting C-terminus, coordinating G-strand synthesis. POT1a conversely negatively regulates telomere length by inhibiting telomerase recruitment.\",\n      \"method\": \"Conditional mouse KO, complementation with POT1a/b swap mutants and point mutants, telomere length assays, telomerase recruitment assays\",\n      \"journal\": \"Nature Communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KOs with domain-swap and point-mutation complementation, multiple mechanistic readouts\",\n      \"pmids\": [\"34535663\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cryo-EM structures of human telomerase bound to TPP1 (3.2 Å) and to TPP1-POT1 (3.9 Å) reveal the interactions required for telomerase recruitment. TPP1-POT1 stabilizes the telomeric DNA in the active site, reveals an unexpected DNA exit path and a DNA anchor site on telomerase important for processivity.\",\n      \"method\": \"Cryo-electron microscopy at 3.2–3.9 Å resolution\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — near-atomic resolution cryo-EM structure of the full telomerase-TPP1-POT1 complex with functional validation\",\n      \"pmids\": [\"35201900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Human POT1 caps the telomeric double-stranded/single-stranded (ds-ss) DNA junction by recognizing the phosphorylated 5' end of the chromosome via a 'POT-hole' surface. Crystal structures reveal the structural basis of junction binding. Mutation of the POT-hole compromises junction protection in vitro and leads to loss of telomeric 5'-end definition and ATR-DDR induction in cells. Mouse POT1a (not POT1b) contains the POT-hole and binds the junction, explaining why POT1a is sufficient for end protection.\",\n      \"method\": \"X-ray crystallography of POT1-junction complex, in vitro binding assays, POT-hole mutagenesis, human cell ATR signaling and telomere end-structure assays\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus mutagenesis and cellular functional validation, explains paralog functional divergence\",\n      \"pmids\": [\"37590346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structures of human CST bound to the shelterin heterodimer POT1/TPP1 reveal how CST is recruited to telomeres by POT1. POT1 hinge phosphorylation is required for CST recruitment. Phosphorylated POT1 holds CST-Polα/primase in an inactive (autoinhibited) state; dephosphorylation of POT1 releases CST-Polα/primase into an active state to perform C-strand fill-in synthesis.\",\n      \"method\": \"Cryo-electron microscopy structure of CST-POT1/TPP1, biochemical assays for POT1 phosphorylation-dependent CST interactions, functional telomere fill-in assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — cryo-EM structure with biochemical and functional validation, disease mutations characterized, mechanistic model for POT1 phospho-switch\",\n      \"pmids\": [\"38838667\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POT1 is the single-stranded telomeric DNA-binding protein of the shelterin complex that caps chromosome ends through two N-terminal OB folds binding the 3' G-rich overhang and a C-terminal OB/HJRL domain heterodimerizing with TPP1; it prevents ATR kinase activation by excluding RPA from telomeric ssDNA (requiring TIN2-mediated tethering to the duplex-binding shelterin components), caps the ds-ss telomere junction via a 'POT-hole' surface recognizing the phosphorylated 5' chromosome end, bidirectionally regulates telomerase processivity (inhibiting when bound at the 3'-terminus; stimulating when POT1-TPP1 coats the overhang via slowed primer dissociation and enhanced translocation), disrupts G-quadruplex structures by conformational selection, recruits CST-Polα/primase in a phosphorylation-dependent manner to enable C-strand fill-in synthesis, and suppresses homology-directed repair at telomeres.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POT1 is the single-stranded telomeric DNA-binding subunit of the shelterin complex that caps chromosome ends and prevents them from being recognized as DNA damage [#0, #12]. Discovered first in fission yeast, where its loss causes telomere erosion and chromosome circularization [#0], POT1 binds the G-rich 3' overhang through tandem N-terminal OB folds that clamp a minimal nonameric recognition site and protect the 3' terminus [#5, #6], discriminating DNA from RNA via a phenylalanine that excludes the ribose 2'-OH [#23]. It is recruited to telomeres not by direct loading alone but through its C-terminal OB/HJRL domain, which heterodimerizes with TPP1 and is thereby tethered through TIN2 to the duplex-binding shelterin proteins TRF1 and TRF2 [#7, #8, #35]; this TIN2-stabilized POT1-TPP1 platform is what excludes RPA from telomeric ssDNA and represses ATR kinase signaling, a pathway POT1 governs independently of TRF2's repression of ATM [#17, #21, #22]. POT1 caps the double-/single-stranded telomere junction by recognizing the phosphorylated 5' chromosome end through a 'POT-hole' surface, defining the precise terminal sequence [#12, #46]. POT1 bidirectionally tunes telomerase: bound at the extreme 3' terminus it inhibits the enzyme, whereas POT1-TPP1 coating the overhang acts as a processivity factor by slowing primer dissociation and enhancing translocation, with cryo-EM revealing how TPP1-POT1 stabilizes the DNA in the telomerase active site [#10, #16, #25, #45]. It resolves telomeric G-quadruplexes by conformational selection to license telomerase access [#9, #40], and, through phosphorylation-dependent recruitment of CST-Polα/primase, controls C-strand fill-in synthesis [#32, #47]. POT1 also suppresses inappropriate homology-directed repair and replication-associated damage at telomeres [#41]. Germline and somatic POT1 mutations cause Coats plus disease and drive cancers by elongating telomeres or by abolishing ssDNA binding to trigger end-to-end fusions [#32, #34, #43].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established that a dedicated protein protects single-stranded chromosome ends, defining the founding function of POT1 before any human mechanism was known.\",\n      \"evidence\": \"Genetic deletion of pot1+ in S. pombe with in vitro ssDNA binding assays\",\n      \"pmids\": [\"11349150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how POT1 recognizes the telomeric sequence at atomic level\", \"Mammalian function and complex partners unaddressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved the structural basis of sequence-specific ssDNA recognition, showing OB-fold loops form a clamp and specificity arises from DNA self-recognition.\",\n      \"evidence\": \"X-ray crystallography of S. pombe Pot1p N-terminal domain bound to ssDNA at 1.9 Å\",\n      \"pmids\": [\"14614509\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Human POT1 architecture not yet defined\", \"How binding relates to telomerase regulation unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Connected POT1 to telomere length homeostasis, positioning it as the terminal transducer of TRF1-mediated length signaling rather than only a passive cap.\",\n      \"evidence\": \"Co-IP, dominant-negative POT1 lacking the DNA-binding domain, and telomere length assays in human cells\",\n      \"pmids\": [\"12768206\", \"12781132\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physical bridge between POT1 and TRF1 not identified\", \"Direction of telomerase regulation mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Defined human POT1's two-OB-fold architecture, minimal recognition site, and identified TPP1/PIP1/PTOP as the adaptor that recruits POT1 to the shelterin core via TIN2.\",\n      \"evidence\": \"Crystal structure of hPOT1 N-terminus at 1.73 Å, EMSA mutagenesis, MS identification and Co-IP of TPP1/PIP1, shRNA knockdown\",\n      \"pmids\": [\"15558049\", \"14715659\", \"15231715\", \"15181449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"C-terminal domain structure and TPP1-binding interface not yet resolved\", \"Mechanism of RPA exclusion not yet shown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrated POT1's dual biochemical roles: resolving G-quadruplexes to permit telomerase, and acting as a position-dependent bidirectional regulator of telomerase.\",\n      \"evidence\": \"Reconstituted in vitro telomerase extension and gel-shift assays with purified recombinant hPOT1\",\n      \"pmids\": [\"16043710\", \"15792951\", \"15632080\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How POT1 switches from inhibitor to activator awaited the TPP1 cofactor\", \"G-quadruplex resolution mechanism (induced fit vs selection) unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Established the cellular consequence of POT1 loss—overhang erosion, loss of 5'-end sequence definition, and a G1 DNA damage response—linking POT1 to terminal structure fidelity.\",\n      \"evidence\": \"RNAi knockdown with overhang assays, DDR foci imaging, telomere sequencing, plus POT1-TRF2 Co-IP and helicase stimulation assays\",\n      \"pmids\": [\"15973431\", \"15657433\", \"16030011\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which DDR kinase POT1 represses not yet specified\", \"Mechanistic basis of 5'-end definition unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Genetic dissection in mouse revealed POT1 paralogs with separable functions—POT1a represses DDR while POT1b controls overhang length—and an aberrant HR phenotype dependent on NBS1.\",\n      \"evidence\": \"Conditional single and double knockouts in mouse cells with complementation, telomere FISH, overhang assays, NBS1 epistasis\",\n      \"pmids\": [\"16839876\", \"16839877\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular determinants distinguishing POT1a from POT1b functions not mapped\", \"Human single-gene equivalence to two mouse paralogs unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined POT1 as the shelterin component that specifically represses the ATR (not ATM) DNA damage pathway, and showed TPP1 binding is required for protection beyond length control.\",\n      \"evidence\": \"Conditional depletion across ATM/ATR-null backgrounds, DDR phosphorylation assays, TPP1 knockdown with POT1-variant complementation\",\n      \"pmids\": [\"17687332\", \"17632522\", \"18535244\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ATR suppression is achieved mechanistically (RPA exclusion) not yet demonstrated\", \"TPP1-POT1 structural basis of telomerase switch unresolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified TPP1 as the cofactor that converts POT1 from a telomerase inhibitor into a processivity factor, with structural similarity to ciliate TEBP-beta.\",\n      \"evidence\": \"Crystal structure of TPP1 OB domain plus reconstituted in vitro telomerase processivity assays with purified POT1-TPP1\",\n      \"pmids\": [\"17237768\", \"17237767\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetic basis of processivity enhancement not yet dissected\", \"Stoichiometry of functional POT1-TPP1 unit unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Established the mechanistic logic of telomere protection: cis ssDNA binding plus TPP1 association are jointly required to exclude RPA, and resolved how POT1 discriminates DNA from RNA.\",\n      \"evidence\": \"Separation-of-function POT1 mutants with RPA co-localization, crystallography of hPOT1 with ribouridine-substituted DNA, F62Y mutagenesis\",\n      \"pmids\": [\"18519588\", \"18955498\", \"20080730\", \"20008939\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How RPA is initially kept off versus replaced over the cell cycle unaddressed\", \"TRF2 contribution to loading vs protection partially separable\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Dissected the kinetic mechanism of telomerase stimulation, showing POT1-TPP1 acts substoichiometrically by slowing primer dissociation and enhancing translocation.\",\n      \"evidence\": \"In vitro telomerase processivity assays with purified POT1-TPP1 and kinetic step analysis\",\n      \"pmids\": [\"20094033\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Behavior when many POT1-TPP1 coat long overhangs not yet examined\", \"Structural contacts with telomerase unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Revealed cell-cycle-regulated handoff of telomeric ssDNA from RPA to POT1, orchestrated by TERRA and hnRNPA1, providing temporal control of POT1 loading.\",\n      \"evidence\": \"Purified protein assays, extract fractionation, RPA/POT1 imaging, TERRA manipulation, plus EM of POT1-TPP1-coated long ssDNA\",\n      \"pmids\": [\"21399625\", \"21596049\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal triggering the switch during the cell cycle not yet defined\", \"Functional role of compacted nucleoprotein structure unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Characterized the dynamics of POT1 and POT1-TPP1 on G-quadruplex and telomeric DNA, showing stepwise OB-fold unfolding versus TPP1-enabled sliding.\",\n      \"evidence\": \"Single-molecule FRET imaging\",\n      \"pmids\": [\"22981946\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab smFRET not independently corroborated\", \"Physiological relevance of sliding in vivo unestablished\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Established TIN2 as the stabilizing tether that maintains TPP1/POT1 on telomeric ssDNA, and showed TIN2-tethered TPP1/POT1 is sufficient for end protection independent of TRF1.\",\n      \"evidence\": \"Conditional knockouts (TIN2, TRF1, BLM, TPP1), TIN2 allele engineering (L247E fusion), epistasis, ATR signaling assays\",\n      \"pmids\": [\"22099311\", \"24469404\", \"25344324\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How phosphorylation of POT1 or partners modulates tethering unaddressed\", \"Direct structural contacts within the subcomplex unresolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified DNA-PKcs phosphorylation of hnRNP-A1 as the kinase signal driving the RPA-to-POT1 switch during G2/M, connecting cell-cycle kinase activity to telomere protection.\",\n      \"evidence\": \"Kinase assays, phospho-mutant expression, RPA/POT1 co-localization, DDR foci assays\",\n      \"pmids\": [\"25999341\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study without independent confirmation\", \"Generality across cell types not established\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined POT1's role in C-strand maintenance via CST and established disease mechanisms—linking the Coats plus S322L mutation and cancer OB-fold mutations to telomere fill-in failure and chromosome fusions.\",\n      \"evidence\": \"Patient and cancer mutation functional characterization, overhang/FISH assays, A-NHEJ assays, conditional KO mouse cancer models, CST/ATR epistasis\",\n      \"pmids\": [\"27013236\", \"27239034\", \"27869160\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct structural basis of POT1-CST recruitment not yet resolved\", \"How phosphorylation governs CST function unaddressed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved the C-terminal POT1 architecture (third OB fold + HJRL domain) and the elongated POT1-TPP1 conformation, explaining how cancer mutations destabilize the complex.\",\n      \"evidence\": \"Two independent crystal structures of POT1C-TPP1 with biochemical binding and cancer-mutation characterization\",\n      \"pmids\": [\"28393832\", \"28393830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of POT1 bound at the ds-ss junction not yet solved\", \"Telomerase-bound conformation unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Uncovered length-dependent telomerase inhibition by multi-POT1-TPP1 coating (via His266), TIN2's contribution to processivity, and proteostatic and tethering regulators of POT1 abundance.\",\n      \"evidence\": \"Hydroxyl-radical footprinting/MS with H266L mutant, in vitro telomerase assays with TIN2/TPP1/POT1, ubiquitination/Co-IP for TSPYL5-USP7, and SerRS pulldown/ChIP\",\n      \"pmids\": [\"31685617\", \"31383750\", \"31278054\", \"31815007\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"His266 conformational switch from single-lab footprinting only\", \"SerRS-POT1 tethering is Low-confidence and not independently confirmed\", \"ALT-specific POT1 degradation pathway not generalized\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Defined HDR suppression as a core human POT1 function and characterized replication-stress phenotypes, including G-quadruplex resolution by conformational selection and nuclear repositioning of dysfunctional telomeres.\",\n      \"evidence\": \"CRISPR conditional deletion in HEK293E with HDR epistasis and proteomics, biophysical G-quadruplex kinetics, BioID and nuclear F-actin imaging in POT1-mutant cells\",\n      \"pmids\": [\"33073402\", \"32232414\", \"33122293\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which HDR factors POT1 directly restrains not fully mapped\", \"Trigger for nuclear-periphery relocalization mechanism incomplete\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Distinguished the cancer-relevant consequence of POT1 mutation as telomere elongation without overt DDR, and assigned the telomerase-recruitment-enhancing role specifically to mouse POT1b.\",\n      \"evidence\": \"CRISPR engineering of caPOT1 mutations in hESCs/HSCs with in vivo competition, conditional mouse KO with POT1a/b swap and point-mutant complementation\",\n      \"pmids\": [\"33934394\", \"34535663\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How the three POT1b C-terminal residues mechanistically enhance recruitment not structurally defined\", \"Human single-gene reconciliation of split paralog roles incomplete\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Provided the structural mechanism of telomerase recruitment, showing how TPP1-POT1 stabilizes telomeric DNA in the active site and defines a DNA exit/anchor path governing processivity.\",\n      \"evidence\": \"Cryo-EM of human telomerase bound to TPP1 (3.2 Å) and TPP1-POT1 (3.9 Å)\",\n      \"pmids\": [\"35201900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Dynamics of recruitment versus the inhibitory 3'-terminal state not captured\", \"How length-dependent inhibition integrates with this structure unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Solved how POT1 caps the ds-ss junction through a 'POT-hole' surface recognizing the phosphorylated 5' end, explaining 5'-end sequence definition and paralog divergence (POT1a contains it).\",\n      \"evidence\": \"Crystal structures of the POT1-junction complex with POT-hole mutagenesis and cellular ATR/end-structure assays\",\n      \"pmids\": [\"37590346\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How junction capping coordinates with overhang coating in vivo unresolved\", \"Regulation of POT-hole engagement across the cell cycle unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined the POT1 phospho-switch that controls CST-Polα/primase: phosphorylated POT1 holds CST inactive, and dephosphorylation releases it for C-strand fill-in synthesis.\",\n      \"evidence\": \"Cryo-EM of CST-POT1/TPP1 with phosphorylation-dependent interaction and telomere fill-in assays, disease mutation characterization\",\n      \"pmids\": [\"38838667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of kinase/phosphatase governing the POT1 hinge switch not established\", \"Temporal coordination with G-strand synthesis unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The upstream signaling that times POT1 phosphorylation/dephosphorylation and integrates G-quadruplex resolution, junction capping, telomerase regulation, and CST fill-in into one cell-cycle program remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No identified enzyme controlling the POT1 hinge phospho-switch\", \"No unified model linking the cap, telomerase, and fill-in functions across the cell cycle\", \"Human reconciliation of the split mouse POT1a/POT1b functions incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 5, 6, 23, 46]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10, 16, 25, 36, 44]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [7, 8, 47]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 12]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [0, 12, 46]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [17, 41, 34]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [29, 33, 47]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [12, 14]}\n    ],\n    \"complexes\": [\n      \"shelterin\",\n      \"POT1-TPP1 heterodimer\"\n    ],\n    \"partners\": [\n      \"TPP1\",\n      \"TIN2\",\n      \"TRF1\",\n      \"TRF2\",\n      \"WRN\",\n      \"BLM\",\n      \"CTC1-STN1-TEN1 (CST)\",\n      \"TSPYL5\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}